JP2005028559A - Nanocapsule - Google Patents
Nanocapsule Download PDFInfo
- Publication number
- JP2005028559A JP2005028559A JP2003292633A JP2003292633A JP2005028559A JP 2005028559 A JP2005028559 A JP 2005028559A JP 2003292633 A JP2003292633 A JP 2003292633A JP 2003292633 A JP2003292633 A JP 2003292633A JP 2005028559 A JP2005028559 A JP 2005028559A
- Authority
- JP
- Japan
- Prior art keywords
- fat
- acid
- soluble
- introduction
- nanocapsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002088 nanocapsule Substances 0.000 title claims description 109
- 239000000126 substance Substances 0.000 claims abstract description 92
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 58
- 239000002245 particle Substances 0.000 claims abstract description 39
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 239000004094 surface-active agent Substances 0.000 claims abstract description 21
- 239000011159 matrix material Substances 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims description 195
- -1 lipid peroxide Chemical class 0.000 claims description 132
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 59
- 239000003963 antioxidant agent Substances 0.000 claims description 51
- 235000006708 antioxidants Nutrition 0.000 claims description 51
- 239000002994 raw material Substances 0.000 claims description 49
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 claims description 41
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 claims description 41
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 claims description 40
- 239000002537 cosmetic Substances 0.000 claims description 31
- 235000011187 glycerol Nutrition 0.000 claims description 31
- 150000003839 salts Chemical class 0.000 claims description 30
- 239000000049 pigment Substances 0.000 claims description 27
- 230000003078 antioxidant effect Effects 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- 239000002131 composite material Substances 0.000 claims description 18
- 150000002500 ions Chemical class 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 15
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 14
- 235000013305 food Nutrition 0.000 claims description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 14
- 239000000976 ink Substances 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 13
- 239000003674 animal food additive Substances 0.000 claims description 11
- 235000013373 food additive Nutrition 0.000 claims description 11
- 239000002778 food additive Substances 0.000 claims description 11
- 235000013376 functional food Nutrition 0.000 claims description 11
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims description 10
- 229910003472 fullerene Inorganic materials 0.000 claims description 10
- 230000003068 static effect Effects 0.000 claims description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 9
- 239000006185 dispersion Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 238000005868 electrolysis reaction Methods 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000003973 paint Substances 0.000 claims description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 5
- 235000013824 polyphenols Nutrition 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
- 230000002292 Radical scavenging effect Effects 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- 239000005515 coenzyme Substances 0.000 claims description 4
- 235000019136 lipoic acid Nutrition 0.000 claims description 4
- 229960002663 thioctic acid Drugs 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 239000003125 aqueous solvent Substances 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 4
- 239000002195 soluble material Substances 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 description 47
- 235000014113 dietary fatty acids Nutrition 0.000 description 46
- 229930195729 fatty acid Natural products 0.000 description 46
- 239000000284 extract Substances 0.000 description 42
- 239000000843 powder Substances 0.000 description 31
- 238000003756 stirring Methods 0.000 description 30
- 238000009472 formulation Methods 0.000 description 29
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- 239000003921 oil Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 27
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 27
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 26
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 24
- 239000011734 sodium Substances 0.000 description 24
- 229910052708 sodium Inorganic materials 0.000 description 24
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 20
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 20
- 229930002330 retinoic acid Natural products 0.000 description 20
- 229960001727 tretinoin Drugs 0.000 description 20
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000002253 acid Substances 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 14
- 239000000499 gel Substances 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 13
- 229940087168 alpha tocopherol Drugs 0.000 description 13
- 239000000975 dye Substances 0.000 description 13
- 229960000984 tocofersolan Drugs 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- 239000002076 α-tocopherol Substances 0.000 description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 12
- 239000004166 Lanolin Substances 0.000 description 12
- 229920001577 copolymer Polymers 0.000 description 12
- 230000006872 improvement Effects 0.000 description 12
- 235000019388 lanolin Nutrition 0.000 description 12
- 229940039717 lanolin Drugs 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 12
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 12
- 235000004835 α-tocopherol Nutrition 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 11
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 11
- 229940032094 squalane Drugs 0.000 description 11
- 239000004475 Arginine Chemical group 0.000 description 10
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical group NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 10
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Chemical group OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 10
- 235000009697 arginine Nutrition 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 235000010382 gamma-tocopherol Nutrition 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 150000005846 sugar alcohols Polymers 0.000 description 10
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 10
- 239000002478 γ-tocopherol Substances 0.000 description 10
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 10
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 9
- 235000021355 Stearic acid Nutrition 0.000 description 9
- 108700003601 dimethylglycine Proteins 0.000 description 9
- 229960000735 docosanol Drugs 0.000 description 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000008117 stearic acid Substances 0.000 description 9
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 239000003945 anionic surfactant Substances 0.000 description 8
- 125000005456 glyceride group Chemical group 0.000 description 8
- 239000002105 nanoparticle Substances 0.000 description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000010452 phosphate Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229920002545 silicone oil Polymers 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- 235000010356 sorbitol Nutrition 0.000 description 7
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 6
- 239000005516 coenzyme A Substances 0.000 description 6
- 229940093530 coenzyme a Drugs 0.000 description 6
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 6
- 239000010445 mica Substances 0.000 description 6
- 229910052618 mica group Inorganic materials 0.000 description 6
- 239000002736 nonionic surfactant Substances 0.000 description 6
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 5
- ZONJATNKKGGVSU-UHFFFAOYSA-M 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC([O-])=O ZONJATNKKGGVSU-UHFFFAOYSA-M 0.000 description 5
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 5
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 5
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 5
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 5
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical group CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 5
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 5
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 5
- YNGACJMSLZMZOX-FPFNAQAWSA-N all-trans-retinyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C YNGACJMSLZMZOX-FPFNAQAWSA-N 0.000 description 5
- 239000011795 alpha-carotene Substances 0.000 description 5
- 235000003903 alpha-carotene Nutrition 0.000 description 5
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 239000001168 astaxanthin Substances 0.000 description 5
- 235000013793 astaxanthin Nutrition 0.000 description 5
- 229940022405 astaxanthin Drugs 0.000 description 5
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 5
- 229940066595 beta tocopherol Drugs 0.000 description 5
- 235000013734 beta-carotene Nutrition 0.000 description 5
- 239000011648 beta-carotene Substances 0.000 description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 5
- 229960002747 betacarotene Drugs 0.000 description 5
- 235000017471 coenzyme Q10 Nutrition 0.000 description 5
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 5
- 239000007857 degradation product Substances 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- 235000012680 lutein Nutrition 0.000 description 5
- 239000001656 lutein Substances 0.000 description 5
- 229960005375 lutein Drugs 0.000 description 5
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 5
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 5
- 229960004999 lycopene Drugs 0.000 description 5
- 235000012661 lycopene Nutrition 0.000 description 5
- 239000001751 lycopene Substances 0.000 description 5
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 5
- 229960003471 retinol Drugs 0.000 description 5
- 235000020944 retinol Nutrition 0.000 description 5
- 239000011607 retinol Substances 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 229940031439 squalene Drugs 0.000 description 5
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 5
- 229940114926 stearate Drugs 0.000 description 5
- 229960004793 sucrose Drugs 0.000 description 5
- 239000011269 tar Substances 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- 239000011731 tocotrienol Substances 0.000 description 5
- 229930003802 tocotrienol Natural products 0.000 description 5
- 235000019148 tocotrienols Nutrition 0.000 description 5
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 5
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 5
- 229940035936 ubiquinone Drugs 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 5
- 235000007680 β-tocopherol Nutrition 0.000 description 5
- 239000011590 β-tocopherol Substances 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- ZFGOPJASRDDARH-UHFFFAOYSA-N 3-[[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C(C2)C1(C)CCC2OC1CC2=CCC3C4CCC(C(C)CCCC(C)C)C4(C)CCC3C2(C)CC1 ZFGOPJASRDDARH-UHFFFAOYSA-N 0.000 description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical group NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical group NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
- 108010028921 Lipopeptides Proteins 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Chemical group NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 239000004472 Lysine Chemical group 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 150000005215 alkyl ethers Chemical class 0.000 description 4
- 229940063655 aluminum stearate Drugs 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 150000007942 carboxylates Chemical class 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- 229940073665 octyldodecyl myristate Drugs 0.000 description 4
- 235000021313 oleic acid Nutrition 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229940108325 retinyl palmitate Drugs 0.000 description 4
- 235000019172 retinyl palmitate Nutrition 0.000 description 4
- 239000011769 retinyl palmitate Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 229960004295 valine Drugs 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 3
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical group CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical group CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008406 cosmetic ingredient Substances 0.000 description 3
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 3
- 229940105990 diglycerin Drugs 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- 235000012732 erythrosine Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Chemical group CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 229960003136 leucine Drugs 0.000 description 3
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 150000003871 sulfonates Chemical class 0.000 description 3
- 239000004474 valine Chemical group 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- HZVFRKSYUGFFEJ-YVECIDJPSA-N (2r,3r,4s,5r)-7-phenylhept-6-ene-1,2,3,4,5,6-hexol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=CC1=CC=CC=C1 HZVFRKSYUGFFEJ-YVECIDJPSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- GLXBPZNFNSLJBS-UHFFFAOYSA-N 11-methyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCC(C)C GLXBPZNFNSLJBS-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- LAIUFBWHERIJIH-UHFFFAOYSA-N 3-Methylheptane Chemical compound CCCCC(C)CC LAIUFBWHERIJIH-UHFFFAOYSA-N 0.000 description 2
- BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical compound OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 description 2
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 2
- JWMBOBQNPBCYER-UHFFFAOYSA-N 4-[(4,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl)oxy]-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound OC1C(CO)OC(O)C(O)C1OC1C(O)C(C2O)OCC2O1 JWMBOBQNPBCYER-UHFFFAOYSA-N 0.000 description 2
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methoxysalicylic acid Chemical compound COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 2
- HMRWHRBSEMHEFA-UHFFFAOYSA-N 6-methylheptyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCC(C)C HMRWHRBSEMHEFA-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 241000208223 Anacardiaceae Species 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical group OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 244000003416 Asparagus officinalis Species 0.000 description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 229910052582 BN Inorganic materials 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Chemical group 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical group O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical group C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical group OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical group OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical group OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical group CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical group OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical group C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- 241000237509 Patinopecten sp. Species 0.000 description 2
- 240000004713 Pisum sativum Species 0.000 description 2
- 235000010582 Pisum sativum Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Chemical group OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Chemical group CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Chemical group 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 2
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical class C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 150000008052 alkyl sulfonates Chemical class 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Chemical group OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 229940078456 calcium stearate Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- DHJGVCITGOCTCA-UHFFFAOYSA-L calcium;hexadecyl phosphate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCOP([O-])([O-])=O DHJGVCITGOCTCA-UHFFFAOYSA-L 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 235000020226 cashew nut Nutrition 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- ZLFVRXUOSPRRKQ-UHFFFAOYSA-N chembl2138372 Chemical compound [O-][N+](=O)C1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 ZLFVRXUOSPRRKQ-UHFFFAOYSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000010634 clove oil Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- XCJYREBRNVKWGJ-UHFFFAOYSA-N copper(II) phthalocyanine Chemical compound [Cu+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 XCJYREBRNVKWGJ-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 235000013681 dietary sucrose Nutrition 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 2
- LEHZBQJZYMFYMK-UHFFFAOYSA-L disodium;hexadecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCOP([O-])([O-])=O LEHZBQJZYMFYMK-UHFFFAOYSA-L 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Chemical group OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- CYKDLUMZOVATFT-UHFFFAOYSA-N ethenyl acetate;prop-2-enoic acid Chemical compound OC(=O)C=C.CC(=O)OC=C CYKDLUMZOVATFT-UHFFFAOYSA-N 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 229920001038 ethylene copolymer Polymers 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Chemical group 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Chemical group OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 235000004554 glutamine Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000008169 grapeseed oil Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- WYVGZXIHGGQSQN-UHFFFAOYSA-N hexadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCCCC(O)=O WYVGZXIHGGQSQN-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 150000002462 imidazolines Chemical class 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229940105112 magnesium myristate Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 150000002739 metals Chemical group 0.000 description 2
- 229930182817 methionine Chemical group 0.000 description 2
- 235000006109 methionine Nutrition 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229940042472 mineral oil Drugs 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- IEDOGKKOPNRRKW-UHFFFAOYSA-N octadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC IEDOGKKOPNRRKW-UHFFFAOYSA-N 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 230000037312 oily skin Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Chemical group OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 235000008729 phenylalanine Nutrition 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000020637 scallop Nutrition 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036548 skin texture Effects 0.000 description 2
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000010675 spruce oil Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 235000008521 threonine Nutrition 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Chemical group OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000002374 tyrosine Nutrition 0.000 description 2
- GAAKLDANOSASAM-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C GAAKLDANOSASAM-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229940041603 vitamin k 3 Drugs 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 229940098697 zinc laurate Drugs 0.000 description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 2
- 229940057977 zinc stearate Drugs 0.000 description 2
- 229940118257 zinc undecylenate Drugs 0.000 description 2
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 2
- KUPGJMJHAFGISS-UHFFFAOYSA-L zinc;hexadecyl phosphate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCOP([O-])([O-])=O KUPGJMJHAFGISS-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FABAOYOFJNAVHB-KVVVOXFISA-N (z)-octadec-9-enoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O FABAOYOFJNAVHB-KVVVOXFISA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Chemical group OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- AFSHUZFNMVJNKX-UHFFFAOYSA-N 1,2-di-(9Z-octadecenoyl)glycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCCCCCCCC AFSHUZFNMVJNKX-UHFFFAOYSA-N 0.000 description 1
- AFSHUZFNMVJNKX-LLWMBOQKSA-N 1,2-dioleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC\C=C/CCCCCCCC AFSHUZFNMVJNKX-LLWMBOQKSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- NBAGECZCEDXIKB-UHFFFAOYSA-N 2-ethylhexanoic acid;hexadecanoic acid Chemical compound CCCCC(CC)C(O)=O.CCCCCCCCCCCCCCCC(O)=O NBAGECZCEDXIKB-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 description 1
- JQXYBDVZAUEPDL-UHFFFAOYSA-N 2-methylidene-5-phenylpent-4-enoic acid Chemical compound OC(=O)C(=C)CC=CC1=CC=CC=C1 JQXYBDVZAUEPDL-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- DSVUBXQDJGJGIC-UHFFFAOYSA-N 3',6'-dihydroxy-4',5'-diiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C(I)=C1OC1=C(I)C(O)=CC=C21 DSVUBXQDJGJGIC-UHFFFAOYSA-N 0.000 description 1
- PYSRRFNXTXNWCD-UHFFFAOYSA-N 3-(2-phenylethenyl)furan-2,5-dione Chemical compound O=C1OC(=O)C(C=CC=2C=CC=CC=2)=C1 PYSRRFNXTXNWCD-UHFFFAOYSA-N 0.000 description 1
- ANRUJJLGVODXIK-UHFFFAOYSA-N 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide Chemical compound NCCC(=O)NCCC1=CN=CN1 ANRUJJLGVODXIK-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- LMNPKIOZMGYQIU-UHFFFAOYSA-N 5-(trifluoromethyl)-1h-pyrimidine-2,4-dione Chemical compound FC(F)(F)C1=CNC(=O)NC1=O LMNPKIOZMGYQIU-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- CDWGDLKZKCYUFO-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-indole-2-carboxylic acid Chemical compound C1=C(C(F)(F)F)C=C2NC(C(=O)O)=CC2=C1 CDWGDLKZKCYUFO-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 240000004507 Abelmoschus esculentus Species 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- ONAIRGOTKJCYEY-XXDXYRHBSA-N CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ONAIRGOTKJCYEY-XXDXYRHBSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000189662 Calla Species 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 244000025596 Cassia laevigata Species 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001655736 Catalpa bignonioides Species 0.000 description 1
- 241000269333 Caudata Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 101800004637 Communis Proteins 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 description 1
- 229930182819 D-leucine Natural products 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- HDOMLWFFJSLFBI-UHFFFAOYSA-N Eriocitrin Natural products CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(Oc4c3)c5ccc(OC6OC(COC7OC(C)C(O)C(O)C7O)C(O)C(O)C6O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O HDOMLWFFJSLFBI-UHFFFAOYSA-N 0.000 description 1
- OMQADRGFMLGFJF-MNPJBKLOSA-N Eriodictioside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=C(O)C(O)=CC=2)O1 OMQADRGFMLGFJF-MNPJBKLOSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000014066 European mistletoe Nutrition 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 description 1
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208251 Gymnema Species 0.000 description 1
- 241000396033 Gymnothorax ocellatus Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000692870 Inachis io Species 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 240000001549 Ipomoea eriocarpa Species 0.000 description 1
- 235000005146 Ipomoea eriocarpa Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical group SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical group OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical group OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical group C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102100032241 Lactotransferrin Human genes 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000009134 Myrica cerifera Nutrition 0.000 description 1
- 240000007695 Nandina domestica Species 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000283220 Odobenus rosmarus Species 0.000 description 1
- 240000008881 Oenanthe javanica Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000287462 Phalacrocorax carbo Species 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical class NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 description 1
- 244000064622 Physalis edulis Species 0.000 description 1
- 235000009074 Phytolacca americana Nutrition 0.000 description 1
- 240000007643 Phytolacca americana Species 0.000 description 1
- 235000010913 Picrasma quassioides Nutrition 0.000 description 1
- 240000004659 Picrasma quassioides Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000305267 Quercus macrolepis Species 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 244000152640 Rhipsalis cassutha Species 0.000 description 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 244000061457 Solanum nigrum Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 229920000147 Styrene maleic anhydride Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 241000691199 Taraxacum platycarpum Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Chemical group C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 241001593968 Vitis palmata Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 description 1
- AWSZRNUJNSWBRK-UHFFFAOYSA-N [Li].[Si](O)(O)(O)O Chemical compound [Li].[Si](O)(O)(O)O AWSZRNUJNSWBRK-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- DGOBMKYRQHEFGQ-UHFFFAOYSA-L acid green 5 Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 DGOBMKYRQHEFGQ-UHFFFAOYSA-L 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DCAYPVUWAIABOU-UHFFFAOYSA-N alpha-n-hexadecene Natural products CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000003918 blood extract Substances 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- UWHUTZOCTZJUKC-JKSUJKDBSA-N brazilin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-JKSUJKDBSA-N 0.000 description 1
- UWHUTZOCTZJUKC-CVEARBPZSA-N brazilin Natural products C12=CC(O)=C(O)C=C2C[C@@]2(O)[C@@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-CVEARBPZSA-N 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 229940043232 butyl acetate Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 108700021352 carcinine Proteins 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 description 1
- 229940114118 carminic acid Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- HBHZKFOUIUMKHV-UHFFFAOYSA-N chembl1982121 Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HBHZKFOUIUMKHV-UHFFFAOYSA-N 0.000 description 1
- PZTQVMXMKVTIRC-UHFFFAOYSA-L chembl2028348 Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 PZTQVMXMKVTIRC-UHFFFAOYSA-L 0.000 description 1
- ONTQJDKFANPPKK-UHFFFAOYSA-L chembl3185981 Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C=C1N=NC1=CC(S([O-])(=O)=O)=C(C=CC=C2)C2=C1O ONTQJDKFANPPKK-UHFFFAOYSA-L 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- 229910000152 cobalt phosphate Inorganic materials 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- ZOOGRGPOEVQQDX-UHFFFAOYSA-N cyclic GMP Natural products O1C2COP(O)(=O)OC2C(O)C1N1C=NC2=C1NC(N)=NC2=O ZOOGRGPOEVQQDX-UHFFFAOYSA-N 0.000 description 1
- 229940095074 cyclic amp Drugs 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Chemical group SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- HDERJYVLTPVNRI-UHFFFAOYSA-N ethene;ethenyl acetate Chemical group C=C.CC(=O)OC=C HDERJYVLTPVNRI-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000054 fungal extract Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Chemical group OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 235000010187 litholrubine BK Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 229940100434 menadiol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- NTNWKDHZTDQSST-UHFFFAOYSA-N naphthalene-1,2-diamine Chemical compound C1=CC=CC2=C(N)C(N)=CC=C21 NTNWKDHZTDQSST-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000010330 ougon Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 229950011087 perflunafene Drugs 0.000 description 1
- UWEYRJFJVCLAGH-IJWZVTFUSA-N perfluorodecalin Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)[C@@]2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[C@@]21F UWEYRJFJVCLAGH-IJWZVTFUSA-N 0.000 description 1
- YVBBRRALBYAZBM-UHFFFAOYSA-N perfluorooctane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YVBBRRALBYAZBM-UHFFFAOYSA-N 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 108010094020 polyglycine Proteins 0.000 description 1
- 229920000232 polyglycine polymer Polymers 0.000 description 1
- 239000005518 polymer electrolyte Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- XIQGQTYUPQAUBV-UHFFFAOYSA-N prop-2-enoic acid;prop-1-en-2-ylbenzene;styrene Chemical compound OC(=O)C=C.C=CC1=CC=CC=C1.CC(=C)C1=CC=CC=C1 XIQGQTYUPQAUBV-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 1
- NIPZZXUFJPQHNH-UHFFFAOYSA-N pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=CC=N1 NIPZZXUFJPQHNH-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 229910052917 strontium silicate Inorganic materials 0.000 description 1
- QSQXISIULMTHLV-UHFFFAOYSA-N strontium;dioxido(oxo)silane Chemical compound [Sr+2].[O-][Si]([O-])=O QSQXISIULMTHLV-UHFFFAOYSA-N 0.000 description 1
- 229920001909 styrene-acrylic polymer Polymers 0.000 description 1
- 229920005792 styrene-acrylic resin Polymers 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- QIWDGSYHBCMXSI-UHFFFAOYSA-J tetrasodium;(2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].C1=CC=CC2=C(OP([O-])([O-])=O)C(C)=CC(OP([O-])([O-])=O)=C21 QIWDGSYHBCMXSI-UHFFFAOYSA-J 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229940105125 zinc myristate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GBFLQPIIIRJQLU-UHFFFAOYSA-L zinc;tetradecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O GBFLQPIIIRJQLU-UHFFFAOYSA-L 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
- AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Fodder In General (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Paints Or Removers (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
Abstract
Description
本発明は、水及び/又は液状マトリックスと、それに溶解、分散された界面活性剤と、脂溶性物質から構成される安定性が良好で安全性が高いナノカプセル及びその用途及びその使用方法に関する。The present invention relates to a nanocapsule having good stability and high safety composed of water and / or a liquid matrix, a surfactant dissolved and dispersed therein, and a fat-soluble substance, its use, and a method for using the same.
従来より、ナノサイズの微小カプセルを得る方法としては、有機ケイ酸を配合する方法、金属石鹸を配合する方法を配合する方法等が知られている。Conventionally, as a method for obtaining nano-sized microcapsules, a method of blending organic silicic acid, a method of blending metal soap, and the like are known.
ドイツ特許DE19846660号は、酸化物粒子に共有結合される有機ケイ素基によって取り囲まれているナノサイズの酸化物粒子もしくは混合酸化物粒子を開示しているがこれらの製造方法は、オルガノシラン及び酸化物成分がプレポリマー中に使用されるため費用がかかる。German patent DE 19846660 discloses nano-sized or mixed oxide particles surrounded by organosilicon groups covalently bonded to the oxide particles. Expensive because the components are used in the prepolymer.
DE19846659号は、反応性の放射線硬化性の基を有するナノサイズのカプセル粒子を作成するためにアクリルオキシアルキルシランの使用を教示している。DE 198464659 teaches the use of acryloxyalkylsilanes to make nano-sized capsule particles with reactive radiation curable groups.
しかしながら、有機ケイ酸を配合する方法ではゲル化させるためにこれらの成分を多量に配合する必要があり、伸展性が悪い、安全性が低く皮膚刺激性が問題となる等の問題があった。また、ナノカプセルが崩れやすく、安定性が十分ではなかった。上記のように従来のナノカプセル組成物はいずれも十分に満足の得られるものではなかった。また、これら従来技術によるナノサイズの微粒子は二次凝集しやすく単層に拡散、塗布等が困難であり工業原料として使用するには粉砕、再分散、再溶解などの処理が必要であり使用上極めて加工が煩雑で取り扱いにくくナノサイズの粒子の性能が十分発揮できないと言う問題があった。However, in the method of blending organosilicic acid, it is necessary to blend a large amount of these components for gelation, and there are problems such as poor extensibility, low safety, and skin irritation. In addition, the nanocapsules were liable to collapse and the stability was not sufficient. As described above, none of the conventional nanocapsule compositions was sufficiently satisfactory. In addition, these nano-sized fine particles according to the prior art tend to agglomerate easily, and are difficult to diffuse and apply to a single layer. In order to use them as industrial raw materials, treatments such as pulverization, re-dispersion, and re-dissolution are necessary. There was a problem that processing was extremely complicated and difficult to handle, and the performance of nano-sized particles could not be fully demonstrated.
本発明の課題は、水及び/又は液状マトリックスと、それに溶解、分散された界面活性剤と、脂溶性物質から構成される安定性が良好で安全性が高く簡便で安価で二次凝集が少ないナノカプセル及びその用途、製造法を提供することである。An object of the present invention is to provide a stable and high-safety simple and inexpensive structure with a low degree of secondary aggregation, comprising water and / or a liquid matrix, a surfactant dissolved and dispersed therein, and a fat-soluble substance. It is to provide a nanocapsule, its use, and production method.
本発明は、安定性が良好で、安全性が高く、脂溶性物質を多量にカプセル内に含有することができ、医薬品、医薬品原料、化粧品、化粧品原料、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、食品、食品添加物、機能性食品,飼料、飼料添加物、老化防止剤、酸化防止剤、抗酸化剤等に好適であるナノサイズのカプセル組成物とその用途、使用方法を提供することを課題とする。The present invention has good stability, high safety, and can contain a large amount of fat-soluble substances in capsules, and can be used for pharmaceuticals, pharmaceutical raw materials, cosmetics, cosmetic raw materials, external preparations, iontophoretic compositions, vibrations. Introduction composition, electromagnetic wave introduction composition, thermal introduction composition, electrolytic introduction composition, food, food additive, functional food, feed, feed additive, anti-aging agent, antioxidant, antioxidant It is an object of the present invention to provide a nano-sized capsule composition suitable for use in the above, its use, and usage.
本発明者らは、上記課題を解決すべく鋭意検討を重ねた結果、界面活性剤、非水系マトリクス、及び脂溶性成分の組み合わせの組成物を水分散させることによりナノカプセルが調製できることを見いだした。さらにこのナノカプセルは極めて安定性が良好で、安全性が高いことを見出し、本発明を完成するに至った。As a result of intensive studies to solve the above problems, the present inventors have found that nanocapsules can be prepared by water-dispersing a combination of a surfactant, a non-aqueous matrix, and a fat-soluble component. . Further, the present inventors have found that the nanocapsules have extremely good stability and high safety, and have completed the present invention.
すなわち本発明は、以下の事項に関する。That is, the present invention relates to the following matters.
水及び/又は液状マトリックスの一種以上の単体又はその複合物と、それに溶解、分散された界面活性剤の一種以上の単体又はその複合物と、脂溶性物質の一種以上の単体又はその複合物から構成されるナノカプセル製造原料用組成物 From one or more simple substances of water and / or a liquid matrix or a composite thereof, one or more simple substances of a surfactant dissolved or dispersed therein or a composite thereof, and one or more simple substances of a fat-soluble substance or a composite thereof. Composition for raw material for producing nanocapsules
請求項1のナノカプセル製造原料用組成物を水に分散することにより形成される1ミクロンメーター以下の範囲、好ましくは999ナノメーターから1ナノメーターの範囲、より好ましくは300ナノメーターから10ナノメターの範囲に平均粒子経をもつナノカプセル A nanocapsule production raw material composition according to claim 1 formed by dispersing in water in a range of 1 micrometer or less, preferably in the range of 999 nanometers to 1 nanometer, more preferably in the range of 300 nanometers to 10 nanometers. Nanocapsules with average particle size in the range
請求項1の界面活性剤がサーファクチン及びその誘導体及びその塩から選択される一種又は混合物である請求項2のナノカプセル The nanocapsule according to claim 2, wherein the surfactant according to claim 1 is one or a mixture selected from surfactin, a derivative thereof and a salt thereof.
請求項1の水及び/又は液状マトリックスがグリセリン及びその誘導体及びその塩から選択される一種又は混合物である請求項2のナノカプセル The nanocapsule according to claim 2, wherein the water and / or liquid matrix according to claim 1 is one or a mixture selected from glycerin and its derivatives and salts thereof.
請求項1の脂溶性物質が抗酸化物質であり好ましくは、一重項酸素、ヒドロキシラジカル、NOラジカル、脂質ペルオキシド等のラジカルスカベンジング効果を有する抗酸化物質であり、より具体的にはビタミンC、ビタミンE、ビタミンA、コエンザイム、リポ酸、ポリフェノール、フラーレン、タール系色素、脂溶性導電性物質類、脂溶性磁気物質類、脂溶性顔料、脂溶性色素類等から選択される脂溶性物質、又は脂溶性誘導体、又は脂溶性物質との複合物、又は脂溶性物質との複合体の一種以上の単体又は混合物である抗酸化物質の誘導体又はプロビタミンである請求項2のナノカプセル The fat-soluble substance of claim 1 is an antioxidant substance, preferably an antioxidant substance having a radical scavenging effect such as singlet oxygen, hydroxy radical, NO radical, lipid peroxide, more specifically vitamin C, A fat-soluble substance selected from vitamin E, vitamin A, coenzyme, lipoic acid, polyphenol, fullerene, tar dye, fat-soluble conductive substance, fat-soluble magnetic substance, fat-soluble pigment, fat-soluble dye, or the like, or The nanocapsule according to claim 2, wherein the nanocapsule is an antioxidant derivative or provitamin which is one or more of a fat-soluble derivative, a complex with a fat-soluble substance, or a complex with a fat-soluble substance.
請求項2のナノカプセルの用途が医薬品、医薬品原料、化粧品、化粧品原料、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、食品、食品添加物、機能性食品,飼料、飼料添加物、老化防止剤、酸化防止剤、抗酸化剤、塗料、トナー、インキジエット用インキ、インクジェットプリント基板、写真フィルム用感光粒子から選択される一種以上の単体又は混合物である請求項2の用途 The nanocapsule according to claim 2 is used for pharmaceuticals, pharmaceutical raw materials, cosmetics, cosmetic raw materials, external preparations, ion introduction compositions, vibration introduction compositions, electromagnetic wave introduction compositions, heat introduction compositions, and electrolytic introduction compositions. Products, foods, food additives, functional foods, feeds, feed additives, antioxidants, antioxidants, antioxidants, paints, toners, ink jet inks, inkjet printed circuit boards, and photosensitive particles for photographic films The use according to claim 2, which is one or more of a simple substance or a mixture
請求項2のナノカプセルをイオン導入、振動導入、電磁波導入、温熱導入、電解導入から選択される一種以上の単法又は混合方法により導入する事により請求項6の用途の効果を高める方法 A method for enhancing the effect of the use according to claim 6 by introducing the nanocapsule according to claim 2 by one or more single methods or a mixing method selected from ion introduction, vibration introduction, electromagnetic wave introduction, heat introduction, and electrolysis introduction.
耐衝撃性で請求項1のナノカプセル製造原料用組成物を少なくとも15/sの剪断速度で剪断変形にかけ、水及び水系溶剤に分散した平均粒子経1000nm未満の微小乳化粒子を製造する方法。 A method for producing fine emulsified particles having an average particle diameter of less than 1000 nm dispersed in water and an aqueous solvent by subjecting the composition for raw material for producing nanocapsules of claim 1 to impact deformation at a shear rate of at least 15 / s.
剪断変形を、スタティックミキサー、ジェットディスパゲーター、ミクロポーラスフィルター、マイクロフルイダイザー及びManton−Gaulinホモジェナイザーノズルから成る群から選ばれる少なくとも1種の分散装置を用いて行う、請求項9に記載の方法。 The method according to claim 9, wherein the shear deformation is performed using at least one dispersion device selected from the group consisting of a static mixer, a jet dispersator, a microporous filter, a microfluidizer, and a Manton-Gaulin homogenizer nozzle. .
以下、本発明を詳細に説明する。
本発明、請求項1の水とは、pH1から13の精製水、イオン交換水、蒸留水、天然水、アルカリイオン水、酸性水、電解イオン水、マイナスイオン水、強酸性水、強アルカリ水等溶媒としてHClを50%重量以上溶解できる水であればよい。Hereinafter, the present invention will be described in detail.
In the present invention, the water of claim 1 is purified water having a pH of 1 to 13, ion exchange water, distilled water, natural water, alkali ion water, acid water, electrolytic ion water, negative ion water, strong acid water, strong alkali water. Any water that can dissolve 50% by weight or more of HCl as an equivalent solvent may be used.
本発明、請求項1の液状マトリックスとは、多価アルコール、グリセリン、エタノール、プロパノール、イソプロパノール、ゲル化剤、グリセリン、ラウリン酸メチル、ラウリルアルコール、モノラウリン酸グリセロール、オレイン酸、オレイルアルコール、モノオレイン酸グリセロール、ジオレイン酸グリセロール及びトリオレイン酸グリセロール、ニコチン酸、2−ピラジンカルボン酸、シナピン酸(3,5−ジメトキシ−4−ヒドロキシケイ皮酸)、2,5−ジヒドロキシ安息香酸、5−メトキシサリチル酸、α−シアノ−4−ヒドロキシケイ皮酸、3−ヒドロキシピコリン酸、ジアミノナフタレン、2−(4−ヒドロキシフェニルアゾ)安息香酸、ジスラノール、コハク酸、5−(トリフルオロメチル)ウラシル等が挙げられる。このうち多価アルコールとしては、例えば、プロピレングリコール、ジプロピレングリコール、ポリプロピレングリコール、グリセリン、ジグリセリン、ポリグリセリン、エチレングリコール、ジエチレングリコール、ポリエチレングリコール、1,3−ブタンジオール、ソルビトール、マルチトール、エリスリトール、ペンタエリスリトール、グルコース、サッカロース、マルトース、キシロース、トレハロース等が例示でき、これらは単独で使用してもよいし、2種以上を組み合わせて使用してもよい。The liquid matrix of the present invention and claim 1 is a polyhydric alcohol, glycerin, ethanol, propanol, isopropanol, gelling agent, glycerin, methyl laurate, lauryl alcohol, glycerol monolaurate, oleic acid, oleyl alcohol, monooleic acid Glycerol, glycerol dioleate and glycerol trioleate, nicotinic acid, 2-pyrazinecarboxylic acid, sinapinic acid (3,5-dimethoxy-4-hydroxycinnamic acid), 2,5-dihydroxybenzoic acid, 5-methoxysalicylic acid, Examples include α-cyano-4-hydroxycinnamic acid, 3-hydroxypicolinic acid, diaminonaphthalene, 2- (4-hydroxyphenylazo) benzoic acid, disranol, succinic acid, and 5- (trifluoromethyl) uracil. Among these, as polyhydric alcohol, for example, propylene glycol, dipropylene glycol, polypropylene glycol, glycerin, diglycerin, polyglycerin, ethylene glycol, diethylene glycol, polyethylene glycol, 1,3-butanediol, sorbitol, maltitol, erythritol, Pentaerythritol, glucose, saccharose, maltose, xylose, trehalose and the like can be exemplified, and these may be used alone or in combination of two or more.
これらのうち好ましいのはグリセリン、ジグリセリン、ポリグリセリン、ソルビトール、マルチトール、エリスリトール、ペンタエリスリトール、グルコース、サッカロース、マルトース、キシロース、トレハロース等の3価以上の多価アルコールであり、特に好ましいのはグリセリン、ソルビトールである。 Of these, preferred are trihydric or higher polyhydric alcohols such as glycerin, diglycerin, polyglycerin, sorbitol, maltitol, erythritol, pentaerythritol, glucose, saccharose, maltose, xylose, trehalose, and particularly preferred is glycerin. Sorbitol.
本発明、請求項1の界面活性剤とは、ナノカプセル製造原料用組成物が調製できるものであればいかなるものも使用することができ、特にリポペプチド構造を有する陰イオン性界面活性剤が適している。本発明に使用できる界面活性剤の具体例としては、アニオン性、カチオン性、非イオン性及び両性の活性剤があるが、本発明では非イオン界面活性剤が使用できる。また、このとき使用できるアニオン性界面活性剤としては、ステアリン酸ナトリウムやパルミチン酸トリエタノールアミン等の脂肪酸セッケン、アルキルエーテルカルボン酸及びその塩、アミノ酸と脂肪酸の縮合等のカルボン酸塩、アルキルスルホン酸、アルケンスルホン酸塩、脂肪酸エステルのスルホン酸塩、脂肪酸アミドのスルホン酸塩、アルキルスルホン酸塩とそのホルマリン縮合物のスルホン酸塩、アルキル硫酸エステル塩、第二級高級アルコール硫酸エステル塩、アルキル及びアリルエーテル硫酸エステル塩、脂肪酸エステルの硫酸エステル塩、脂肪酸アルキロールアミドの硫酸エステル塩、ロート油等の硫酸エステル塩類、アルキルリン酸塩、エーテルリン酸塩、アルキルアリルエーテルリン酸塩、アミドリン酸塩、N−アシルアミノ酸系活性剤等、カチオン性界面活性剤としては、アルキルアミン塩、ポリアミン及びアミノアルコール脂肪酸誘導体等のアミン塩、アルキル四級アンモニウム塩、芳香族四級アンモニウム塩、ピリジウム塩、イミダゾリウム塩等;非イオン性界面活性剤としては、ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ポリエチレングリコール脂肪酸エステル、ショ糖脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシプロピレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビトール脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンプロピレングリコール脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンフィトスタノールエーテル、ポリオキシエチレンフィトステロールエーテル、ポリオキシエチレンコレスタノールエーテル、ポリオキシエチレンコレステリルエーテル、ポリオキシアルキレン変性オルガノポリシロキサン、ポリオキシアルキレン・アルキル共変性オルガノポリシロキサン、アルカノールアミド、糖エーテル、糖アミド等;両性界面活性剤としては、ベタイン、アミノカルボン酸塩、イミダゾリン誘導体等、その他の界面活性剤成分としては、12−ヒドロキシステアリン酸アルミニウム、ステアリン酸亜鉛、ステアリン酸アルミニウム、ステアリン酸カルシウム、ステアリン酸マグネシウム、ミリスチン酸亜鉛、ミリスチン酸マグネシウム、セチルリン酸亜鉛、セチルリン酸カルシウム、セチルリン酸亜鉛ナトリウム、ラウリン酸亜鉛、ウンデシレン酸亜鉛が挙げられるがこれらに限定されない。 Any surfactant can be used as the surfactant of the present invention and claim 1 as long as it can prepare a composition for a raw material for producing nanocapsules, and an anionic surfactant having a lipopeptide structure is particularly suitable. ing. Specific examples of the surfactant that can be used in the present invention include anionic, cationic, nonionic and amphoteric active agents. In the present invention, nonionic surfactants can be used. Examples of the anionic surfactant that can be used at this time include fatty acid soaps such as sodium stearate and triethanolamine palmitate, alkyl ether carboxylic acids and salts thereof, carboxylates such as condensation of amino acids and fatty acids, and alkyl sulfonic acids. Alkene sulfonate, fatty acid ester sulfonate, fatty acid amide sulfonate, alkyl sulfonate and its formalin condensate sulfonate, alkyl sulfate ester, secondary higher alcohol sulfate ester, alkyl and Allyl ether sulfate ester, fatty acid ester sulfate ester salt, fatty acid alkylolamide sulfate ester salt, sulfuric acid ester salt such as funnel oil, alkyl phosphate, ether phosphate, alkyl allyl ether phosphate, amide phosphate N-acyl Examples of cationic surfactants such as mino acid-based surfactants include amine salts such as alkylamine salts, polyamines and aminoalcohol fatty acid derivatives, alkyl quaternary ammonium salts, aromatic quaternary ammonium salts, pyridium salts, imidazolium salts, etc. Nonionic surfactants include sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, propylene glycol fatty acid ester, polyethylene glycol fatty acid ester, sucrose fatty acid ester, polyoxyethylene alkyl ether, polyoxypropylene alkyl ether, Polyoxyethylene alkyl phenyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbitol fatty acid ester, poly Xylethylene glycerin fatty acid ester, polyoxyethylene propylene glycol fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene phytostanol ether, polyoxyethylene phytosterol ether, polyoxyethylene cholestanol ether, polyoxyethylene Cholesteryl ether, polyoxyalkylene-modified organopolysiloxane, polyoxyalkylene / alkyl co-modified organopolysiloxane, alkanolamide, sugar ether, sugar amide, etc .; amphoteric surfactants include betaine, aminocarboxylate, imidazoline derivatives, etc. Other surfactant components include 12-hydroxy aluminum stearate, zinc stearate, aluminum stearate , Calcium stearate, magnesium stearate, zinc myristate, magnesium myristate, zinc cetyl phosphate, calcium cetyl phosphate, sodium cetyl phosphate, zinc laurate, zinc undecylenate, but are not limited thereto.
リポペプチド構造を有する陰イオン性界面活性剤としては、例えばサーファクチン、その類縁化合物、及び/またはそれらの塩が挙げられる。 Examples of the anionic surfactant having a lipopeptide structure include surfactin, its related compounds, and / or salts thereof.
本発明の界面活性剤の含有量は特に制限はないが、好ましくは組成物全量(本発明において「組成物全量」とは、界面活性剤、水及び/又は液状マトリックス、及び脂溶性物質の総量をいう。以下同じ。)に対して0.01〜45質量%、より好ましくは0.1〜20質量%である。界面活性剤の量が0.01質量%未満では十分にナノカプセルを作ることができず、また45質量%を超えて使用すると粘度が高くなり過ぎるため、好ましくない。 The content of the surfactant of the present invention is not particularly limited, but preferably the total amount of the composition (in the present invention, “the total amount of the composition” means the total amount of surfactant, water and / or liquid matrix, and fat-soluble substance). The same shall apply hereinafter.) 0.01 to 45% by mass, and more preferably 0.1 to 20% by mass. When the amount of the surfactant is less than 0.01% by mass, nanocapsules cannot be sufficiently produced, and when the amount exceeds 45% by mass, the viscosity becomes too high.
本発明、請求項1の脂溶性物質とは、1気圧25℃で液状またはペースト状のものが好ましく、液状油が好ましい。請求項1の脂溶性物質は抗酸化物質が好ましく、一重項酸素、ヒドロキシラジカル、NOラジカル、脂質ペルオキシド等のラジカルスカベンジング効果を有する抗酸化物質であり、より好ましくはビタミンC、ビタミンE、ビタミンA、コエンザイム、フラーレン、リポ酸、ポリフェノールから選択される脂溶性物質又は脂溶性誘導体の一種以上の単体又は混合物である。The fat-soluble substance of the present invention and claim 1 is preferably liquid or pasty at 1 atm 25 ° C., and preferably liquid oil. The fat-soluble substance of claim 1 is preferably an antioxidant, and is an antioxidant having a radical scavenging effect such as singlet oxygen, hydroxy radical, NO radical, lipid peroxide, and more preferably vitamin C, vitamin E, vitamin A, a single substance or a mixture of fat-soluble substances or fat-soluble derivatives selected from coenzyme, fullerene, lipoic acid, and polyphenol.
本発明、請求項1の脂溶性物質としては、例えば、炭化水素類、高級アルコールエステル類、高級脂肪酸エステル類、トリグリセリド類、シリコーン油類、高級アルコール類、高級脂肪酸類、動植物油類、コレステロール脂肪酸エステル類、ステロール類、ステロールエステル類、ポリフェノール、フラーレン、タール、タール系色素、脂溶性導電性物質、脂溶性磁気物質類、脂溶性顔料、脂溶性色素類等が挙げられ、好ましいものとしては、アスコルビン酸イソパルミチン酸、アスコルビン酸−2−リン酸−6−パルミテート、アスコルビン酸−2−リン酸−6−イソパルミテート、アスコルビン酸−6−パルミテート、アスコルビン酸−2、6−ジパルミテート、アスコルビン酸−6−ステアレート、レチノール、レチノイン酸、レチノールパルミテート、レチノイン酸パルミテート、レチノイン酸イソパルミテート、レチノイン酸ステアレート、レチノールステアレート、アスタキサンチン、ルテイン、リコピン、βカロチン、αカロチン、αトコフェロール、βトコフェロール、γトコフェロール、ジメチルグリシンγトコフェロール、ジメチルグリシンαトコフェロール、ユビキノン、コエンザイムA、トコトリエノール、ミネラル油、流動パラフィン、スクアラン、パルミチン酸イソプロピル、ミリスチン酸イソプロピル、ミリスチン酸イソオクチル、ミリスチン酸イソトリデシル、ミリスチン酸オクタデシル、ミリスチン酸オクチルドデシル、イソステアリルコレステリルエステル、2−エチルヘキサン酸トリグリセリド、2−エチルヘキサン酸セチル、ヒマワリ油、オリーブ油、ホホバ油、ツバキ油、グレープシード油、アボガド油、マカダミアナッツ油、アーモンド油、米胚芽油、丁字油、オレンジ油、トウヒ油、オクタメチルトリシロキサン、デカメチルテトラシロキサン、メチルポリシロキサン、高重合メチルポリシロキサン等のジメチルシリコーン油;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、メチルシクロポリシロキサン、メチルポリシクロシロキサン等の環状シリコーン油;ポリエーテル変性シリコーン油、メチルフェニルポリシロキサン等のメチルフェニルシリコーン油等が挙げられる。これらは単独で使用してもよいし、2種以上を組み合わせて使用してもよい。 Examples of the fat-soluble substance of the present invention and claim 1 include, for example, hydrocarbons, higher alcohol esters, higher fatty acid esters, triglycerides, silicone oils, higher alcohols, higher fatty acids, animal and vegetable oils, cholesterol fatty acids Examples include esters, sterols, sterol esters, polyphenols, fullerenes, tars, tar dyes, fat-soluble conductive substances, fat-soluble magnetic substances, fat-soluble pigments, fat-soluble dyes, and the like. Ascorbic acid isopalmitic acid, ascorbic acid-2-phosphate-6-palmitate, ascorbic acid-2-phosphate-6-isopalmitate, ascorbic acid-6-palmitate, ascorbic acid-2,6-dipalmitate, ascorbic acid-6 Stearate, retinol, retinoic acid, retino Lupalmitate, retinoic acid palmitate, retinoic acid isopalmitate, retinoic acid stearate, retinol stearate, astaxanthin, lutein, lycopene, β-carotene, α-carotene, α-tocopherol, β-tocopherol, γ-tocopherol, dimethylglycine γ-tocopherol, dimethylglycine-α-tocopherol Ubiquinone, coenzyme A, tocotrienol, mineral oil, liquid paraffin, squalane, isopropyl palmitate, isopropyl myristate, isooctyl myristate, isotridecyl myristate, octadecyl myristate, octyldodecyl myristate, isostearyl cholesteryl ester, 2-ethylhexanoic acid Triglyceride, cetyl 2-ethylhexanoate, sunflower oil, oil Ove oil, jojoba oil, camellia oil, grape seed oil, avocado oil, macadamia nut oil, almond oil, rice germ oil, clove oil, orange oil, spruce oil, octamethyltrisiloxane, decamethyltetrasiloxane, methylpolysiloxane Dimethyl silicone oil such as highly polymerized methylpolysiloxane; cyclic silicone oil such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, methylcyclopolysiloxane, methylpolycyclosiloxane; polyether-modified silicone oil And methylphenyl silicone oil such as methylphenylpolysiloxane. These may be used alone or in combination of two or more.
本発明に使用できる上記記載の代表的な脂溶性顔料、脂溶性色素には、
(ピグメントレッド123,C.I.No.71145)、トルイジンレッドB(C.I.ピグメン
イエローG(C.I.ピグメントイエロー1)、ピグメントスカーレット(C.I.ピグメントレッド60)、Auric Brown(C.I.ピグメントブラウン6)等が含まれる。本発明のインキの配合に有用な他の典型的な顔料は、フタロシアニンブルー(C.I.74260)、フタロシアニングリーン(C.I.74260)、Hanza
イエロー3G(C.I.11670)、ジアゾイエローGR(C.I.21100)、パーマネントレッド4R(C.I.12335)、ブリリアントカーミン6B(C.I.15850)及びキナクリドンレッド(C.I.46500)である。これらの顔料、色素で脂溶性特性が低い場合は、前記記載の脂溶性物質に0.1〜95%重量の含量で分散した組成物を使用することもできる。Representative fat-soluble pigments and fat-soluble dyes described above that can be used in the present invention include:
(Pigment Red 123, CI No. 71145), Toluidine Red B (CI Pigment)
Yellow G (CI Pigment Yellow 1), Pigment Scarlet (CI Pigment Red 60), Auric Brown (CI Pigment Brown 6), and the like are included. Other typical pigments useful in formulating the inks of the present invention are phthalocyanine blue (CI. 74260), phthalocyanine green (CI. 74260), Hanza.
Yellow 3G (C.I. 11670), Diazo Yellow GR (C.I. 21100), Permanent Red 4R (C.I. 12335), Brilliant Carmine 6B (C.I. 15850) and Quinacridone Red (C.I. 46500). When these pigments and dyes have low fat-soluble properties, it is also possible to use a composition dispersed in the above-described fat-soluble substance at a content of 0.1 to 95% by weight.
本発明の請求項5の脂溶性導電性物質類、脂溶性磁気物質類、脂溶性顔料としてナノサイズ以下の金属または金属酸化物の微粒子を前記脂溶性物質に0.1〜95%重量の含量で分散した金属または金属酸化物の油状組成物を使用することもできる。このとき使用できる金属及び金属酸化物は、例えば磁性インキジェットインキの製造に適している。微細な粒径の酸化物、例えばシリカ、アルミナ、チタニア等も選択され得る。さらに、微細に粉砕された金属粒子、例えば銅、鉄、鋼鉄、アルミニウム及び合金も適当な用途に選択され得る。 Content of 0.1 to 95% by weight of lipid-soluble conductive substances, lipid-soluble magnetic substances, and nano-sized metal or metal oxide fine particles as fat-soluble pigments in claim 5 of the present invention. It is also possible to use oily compositions of metals or metal oxides dispersed in The metals and metal oxides that can be used at this time are suitable for the production of magnetic ink jet inks, for example. Fine particle size oxides such as silica, alumina, titania and the like may also be selected. In addition, finely ground metal particles such as copper, iron, steel, aluminum and alloys can be selected for suitable applications.
本発明、請求項5の脂溶性顔料、脂溶性色素類等に使用するのに特に好ましい顔料は、C.I.ピグメントレッド122、C.I.ビグメントイエロー74及びC.I.ピグメントブルー15である。本発明は、特に、カラー顔料に使用する場合に有利である。ナノカプセルに含有される顔料の量は、全組成物に対して、通常は10〜50重量%である。より好ましくは、顔料の量は10〜25重量%の範囲である。 Particularly preferred pigments for use in the present invention, the fat-soluble pigment of claim 5 and the fat-soluble dyes, are C.I. I. Pigment red 122, C.I. I. Pigment yellow 74 and C.I. I. Pigment Blue 15. The present invention is particularly advantageous when used for color pigments. The amount of the pigment contained in the nanocapsule is usually 10 to 50% by weight with respect to the total composition. More preferably, the amount of pigment is in the range of 10-25% by weight.
請求項5の脂溶性導電性物質類、脂溶性磁気物質類として高分子電解質を使用することもでき、好ましくは高分子カルボン酸塩である。この塩は、カルボン酸のナトリウム塩、カリウム塩またはリチウム塩、アンモニウム塩であればよい。 A polymer electrolyte can also be used as the fat-soluble conductive substances and the fat-soluble magnetic substances according to claim 5, and is preferably a polymer carboxylate. This salt may be a sodium salt, potassium salt, lithium salt or ammonium salt of carboxylic acid.
本発明に使用できる高分子カルボン酸塩は、特に下記のポリマーの塩である:ポリアクリル酸、アクリル酸−アクリルニトリルコポリマー、アクリル酸カリウム−アクリロニトリルコポリマー、酢酸ビニル−アクリル酸エステルコポリマー及びアクリル酸−アクリル酸アルキルエステルコポリマーのようなアクリル樹脂、スチレン−アクリル酸コポリマー、スチレン−メタクリル酸コポリマー、スチレン−メタクリル酸−アクリル酸アルキルエステルコポリマー、スチレン−α−メチルスチレン−アクリル酸コポリマー及びスチレン−α−メチルスチレン−アクリル酸−アクリル酸アルキルエステルコポリマーのようなスチレンアクリル樹脂;スチレン−マレイン酸コポリマー、スチレン−無水マレイン酸コポリマー;ビニルナフタレン−アクリル酸コポリマー、酢酸ビニル−エチレンコポリマー、酢酸ビニル−脂肪酸ビニルエチレンコポリマー、酢酸ビニル−マレイン酸エステルコポリマー、酊酸ビニル−クロトン酸コポリマー及び酢酸ビニル−アクリル酸コポリマーのような酢酸ビニル樹脂;並びに任意のポリエステルまたはセルロースポリマーの塩。 The polymeric carboxylates that can be used in the present invention are in particular the salts of the following polymers: polyacrylic acid, acrylic acid-acrylonitrile copolymer, potassium acrylate-acrylonitrile copolymer, vinyl acetate-acrylic acid ester copolymer and acrylic acid- Acrylic resins such as alkyl acrylate copolymers, styrene-acrylic acid copolymers, styrene-methacrylic acid copolymers, styrene-methacrylic acid-acrylic acid alkyl ester copolymers, styrene-α-methylstyrene-acrylic acid copolymers and styrene-α-methyl. Styrene acrylic resins such as styrene-acrylic acid-alkyl acrylate ester copolymers; styrene-maleic acid copolymers, styrene-maleic anhydride copolymers; vinylnaphthalene-acrylic Vinyl acetate resins such as lauric acid copolymers, vinyl acetate-ethylene copolymers, vinyl acetate-fatty acid vinyl ethylene copolymers, vinyl acetate-maleic acid ester copolymers, vinyl oxalate-crotonic acid copolymers and vinyl acetate-acrylic acid copolymers; and optional Salt of polyester or cellulose polymer.
高分子電解質として適する界面活性剤は、例えば、高分子アルキルスルフェート、高分子アルコール硫酸エステルの塩、高分子脂肪酸とアミノ酸との縮合生成物、スルホスクシネート、ナフタネート、液体脂肪油硫酸エステルの塩及びアルキルアリルスルフェートのようなアニオン界面活性剤;4級アンモニウム塩、スルホニウム塩及びホスホニウムのようなカチオン界面活性剤:並びにポリオキシエチレンアルキルエステル、ソルビタンアルキルエステル及びポリオキシエチレンソルビタンアルキルエステルのようなノニオン界面活性剤を含む。高分子電解質の適する量は、全組成物に対して、約0.05〜10重量%、好ましくは0.1〜3重量%の範囲である。 Surfactants suitable as polyelectrolytes include, for example, polymeric alkyl sulfates, polymeric alcohol sulfate salts, condensation products of polymeric fatty acids and amino acids, sulfosuccinates, naphthanates, and liquid fatty oil sulfates. Anionic surfactants such as salts and alkyl allyl sulfates; cationic surfactants such as quaternary ammonium salts, sulfonium salts and phosphonium: and such as polyoxyethylene alkyl esters, sorbitan alkyl esters and polyoxyethylene sorbitan alkyl esters Nonionic surfactants. Suitable amounts of polyelectrolyte range from about 0.05 to 10% by weight, preferably 0.1 to 3% by weight, based on the total composition.
本発明のナノカプセル製造原料用組成物における脂溶性物質の好ましい含有量は、組成物全量に対して、1〜99.9質量%であり、50〜95質量%がより好ましい。 The preferable content of the fat-soluble substance in the composition for producing nanocapsules of the present invention is 1 to 99.9% by mass, and more preferably 50 to 95% by mass with respect to the total amount of the composition.
本発明の請求項1のナノカプセル製造原料用組成物における水及び/又は液状マトリックスの好ましい含有量は、組成物全量に対して0.01〜43質量%であり、0.05〜39質量%がより好ましく、0.1〜36質量%がさらに好ましい。 The preferred content of water and / or liquid matrix in the composition for producing nanocapsules according to claim 1 of the present invention is 0.01 to 43% by mass, and 0.05 to 39% by mass with respect to the total amount of the composition. Is more preferable, and 0.1-36 mass% is further more preferable.
本発明のナノカプセル製造原料用組成物は、例えば、多価アルコール及び/または水にリポペプチド構造を有する陰イオン性界面活性剤を溶解し、撹拌しながら脂溶性物質を少量ずつ添加していくこと等により調製することができる。多価アルコールと水を併用する場合は、水は脂溶性物質を添加した後に添加してもよい。 In the composition for raw material for producing nanocapsules of the present invention, for example, an anionic surfactant having a lipopeptide structure is dissolved in polyhydric alcohol and / or water, and a fat-soluble substance is added little by little while stirring. It can prepare by. When polyhydric alcohol and water are used in combination, water may be added after adding the fat-soluble substance.
脂溶性物質は、所定量ずつ添加(分割添加)しても、連続的に添加(連続添加)してもよい。分割添加の場合には、既に添加されている多価アルコール及び/または水の量の60質量%以下、好ましくは30質量%以下、より好ましくは10質量%以下の量を一度に添加し、撹拌して均一にする。それを繰り返すことにより必要量を添加する。連続添加の場合、添加速度は既に添加されている多価アルコール及び/または水の量の60質量%/分以下、好ましくは30質量%/分以下、より好ましくは10質量%/分以下である。 The fat-soluble substance may be added in predetermined amounts (divided addition) or continuously (continuous addition). In the case of divided addition, an amount of 60% by mass or less, preferably 30% by mass or less, more preferably 10% by mass or less of the amount of polyhydric alcohol and / or water already added is added at one time and stirred. And make it uniform. Add the required amount by repeating it. In the case of continuous addition, the addition rate is 60% by mass / min or less, preferably 30% by mass / min or less, more preferably 10% by mass / min or less of the amount of polyhydric alcohol and / or water already added. .
また、他の成分を添加する場合は、脂溶性物質を添加する前に添加しても、脂溶性物質に溶解または分散させて添加しても、脂溶性物質を全量添加した後に添加しても、脂溶性物質を添加している途中で添加してもいずれの方法でもかまわない。多価アルコール及び/または水は、最初に全量を添加しても、添加量の一部を最初に使用して残りを後から添加してもよい。
本発明、請求項2のナノカプセルの平均粒子径は、1ミクロンメーター以下の範囲、好ましくは999ナノメーターから1ナノメーターの範囲、より好ましくは700ナノメーターから10ナノメターの範囲に平均粒子経をもつナノカプセルであれば良い。In addition, when adding other components, it may be added before adding the fat-soluble substance, dissolved or dispersed in the fat-soluble substance, or added after the total amount of the fat-soluble substance is added. Any method may be used even if it is added during the addition of the fat-soluble substance. The polyhydric alcohol and / or water may be added in the total amount at first, or a part of the added amount may be used first and the rest may be added later.
The average particle diameter of the nanocapsules according to the present invention and claim 2 has an average particle diameter in the range of 1 micrometer or less, preferably in the range of 999 nanometers to 1 nanometer, more preferably in the range of 700 nanometers to 10 nanometers. Any nanocapsule may be used.
本発明、請求項3のサーファクチン及びその誘導体及びその塩とは、一般式(I)
で示される化合物、またはこの化合物を2種以上含有する組成物である。上記一般式(I)において、Xは、ロイシン、イソロイシン、バリン、グリシン、セリン、アラニン、トレオニン、アスパラギン、グルタミン、アスパラギン酸、グルタミン酸、リジン、アルギニン、システイン、メチオニン、フェニルアラニン、チロシン、トリプトファン、ヒスチジン、プロリン、4−ヒドロキシプロリン及びホモセリンからなる群から選ばれるアミノ酸残基を表わす。好ましいXはロイシン、イソロイシンまたはバリンである。The surfactin of the present invention, claim 3 and derivatives thereof and salts thereof are represented by the general formula (I)
Or a composition containing two or more of these compounds. In the general formula (I), X is leucine, isoleucine, valine, glycine, serine, alanine, threonine, asparagine, glutamine, aspartic acid, glutamic acid, lysine, arginine, cysteine, methionine, phenylalanine, tyrosine, tryptophan, histidine, It represents an amino acid residue selected from the group consisting of proline, 4-hydroxyproline and homoserine. Preferred X is leucine, isoleucine or valine.
Rは、炭素数8〜14のノルマルアルキル基、炭素数8〜14のイソアルキル基または炭素数8〜14のアンテイソアルキル基である。ノルマルアルキル基は直鎖アルキル基、イソアルキル基は通常(CH3)2CH−(CH2)n−からなる構造であり、アンテイソアルキル基は通常CH3−CH2−CH(CH3)−(CH2)n−からなる構造である。サーファクチンの類縁化合物とは、上記一般式(I)のアミノ酸が他のアミノ酸に置き換わったものをいう。具体的には二番目のL−ロイシン、四番目のL−バリン、六番目のD−ロイシン等が他のアミノ酸に置き換わったものが挙げられるが、これらに限定されない。以下、「サーファクチン及び/またはその類縁化合物」を「サーファクチン」ということがある。R is a normal alkyl group having 8 to 14 carbon atoms, an isoalkyl group having 8 to 14 carbon atoms, or an anteisoalkyl group having 8 to 14 carbon atoms. The normal alkyl group is a straight chain alkyl group, the isoalkyl group is usually a structure consisting of (CH 3 ) 2 CH— (CH 2 ) n —, and the anteisoalkyl group is usually CH 3 —CH 2 —CH (CH 3 ) —. it is made of the structure - (CH 2) n. Surfactin-related compounds refer to compounds in which the amino acid of the above general formula (I) is replaced with another amino acid. Specific examples include, but are not limited to, those in which the second L-leucine, the fourth L-valine, the sixth D-leucine and the like are replaced with other amino acids. Hereinafter, “surfactin and / or its related compounds” may be referred to as “surfactin”.
サーファクチンは、通常は原核生物により生産される。原核生物としては、一般にバチルスズブチリス(Bacillus subtilis)IAM1213株、IAM1069株、IAM1259株、IAM1260株、IFO3035株、ATCC21332株等のバチルス属微生物が用いられる。
この微生物を培養し、精製することにより容易にサーファクチンを得ることができる。精製は、例えば培養液を塩酸等の添加により酸性にし、沈殿したサーファクチンを濾別し、メタノール等の有機溶媒に溶解し、その後適宜限外濾過、活性炭処理、結晶化等を行なうことによってなされる。酸添加による沈殿はカルシウム塩の添加による沈殿におきかえてもよい(Biochem.Bioph.Res.Commun.,31:488−494(1968))。サーファクチンは、上記バチルス属微生物等の原核生物によって産生されるもののほか、他の製法、例えば化学合成法によって得られるものでも同様に使用することができる。サーファクチンは、上記一般式(I)から分かるように無機塩や有機塩として利用することができる。対イオンとなる金属はナトリウム、カリウム、リチウム等のアルカリ金属、カルシウム、マグネシウム等のアルカリ土類金属等をはじめとしてサーファクチンと塩を形成するものであれば種類を問わない。Surfactin is usually produced by prokaryotes. As prokaryotes, Bacillus subtilis IAM1213 strain, IAM1069 strain, IAM1259 strain, IAM1260 strain, IFO3035 strain, ATCC21332 strain and the like are generally used.
Surfactin can be easily obtained by culturing and purifying the microorganism. The purification is performed, for example, by acidifying the culture solution by adding hydrochloric acid or the like, filtering the precipitated surfactin, dissolving it in an organic solvent such as methanol, and thereafter performing ultrafiltration, activated carbon treatment, crystallization, etc. The Precipitation by addition of acid may be replaced by precipitation by addition of calcium salt (Biochem. Bioph. Res. Commun., 31 : 488-494 (1968)). Surfactin can be used in the same manner as that produced by prokaryotic organisms such as the aforementioned Bacillus microorganisms, as well as those obtained by other production methods such as chemical synthesis. Surfactin can be used as an inorganic salt or an organic salt as can be seen from the above general formula (I). Any metal can be used as the counter ion as long as it forms a salt with surfactin, including alkali metals such as sodium, potassium and lithium, alkaline earth metals such as calcium and magnesium.
有機塩類としてはトリメチルアミン、トリエチルアミン、トリブチルアミン、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、リジン、アルギニン、コリン等を挙げることができる。Examples of organic salts include trimethylamine, triethylamine, tributylamine, monoethanolamine, diethanolamine, triethanolamine, lysine, arginine, choline and the like.
これらの中でもナトリウム、カリウム、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、リジン、アルギニンが好ましく、特にナトリウムが好ましい。サーファクチンのナトリウム塩は、サーファクチンナトリウムとして昭和電工株式会社からアミノフェクト(昭和電工株式会社登録商標)の商品名で販売されているものを使用することができる。Among these, sodium, potassium, monoethanolamine, diethanolamine, triethanolamine, lysine and arginine are preferable, and sodium is particularly preferable. Surfactin sodium salt can be used as surfactin sodium sold by Showa Denko Co., Ltd. under the trade name Aminofect (registered trademark of Showa Denko KK).
サーファクチン、その類縁化合物、及び/またはそれらの塩などのリポペプチド構造を有する陰イオン性界面活性剤は、皮膚に対し極めて低刺激性である。サーファクチン、その類縁化合物、及び/またはそれらの塩が皮膚に対して低刺激性であるのはサーファクチン及びその類縁化合物が複雑な環状化合物で嵩高なため、皮膚浸透性が小さいことによると考えられる。またサーファクチン、その類縁化合物、及び/またはそれらの塩が皮膚刺激性物質を取り囲むマスキング効果により刺激性物質の刺激性を低減するものと考えられる。本発明においては、サーファクチンの塩及び/またはサーファクチンの類縁化合物の塩が好ましく用いられ、極めて皮膚刺激性の低いナノカプセル製造原料用組成物が提供される。Anionic surfactants having a lipopeptide structure such as surfactin, its analogs, and / or their salts are very mild to the skin. Surfactin, its related compounds, and / or their salts are hypoallergenic to the skin, because surfactin and its related compounds are complex cyclic compounds and bulky, and are considered to be due to their low skin permeability. It is done. It is also considered that surfactin, its related compounds, and / or their salts reduce the irritation of the irritating substance due to the masking effect surrounding the skin irritating substance. In the present invention, a salt of surfactin and / or a salt of a related compound of surfactin is preferably used, and a composition for a raw material for producing nanocapsules having extremely low skin irritation is provided.
本発明のナノカプセルの用途が医薬品、医薬品原料、化粧品、化粧品原料、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、食品、食品添加物、機能性食品,飼料、飼料添加物、老化防止剤、酸化防止剤、抗酸化剤の場合、本発明、請求項1の脂溶性物質として好ましくは、脂溶性物質が抗酸化物質でありより好ましくは、一重項酸素、ヒドロキシラジカル、NOラジカル、脂質ペルオキシド等のラジカルスカベンジング効果を有する抗酸化物質であり、より具体的にはビタミンC、ビタミンE、ビタミンA、コエンザイム、フラーレン、リポ酸、ポリフェノールから選択される脂溶性物質又は脂溶性誘導体の一種以上の単体又は混合物である抗酸化物質の誘導体又はプロビタミンであればよい。本発明で使用されるフラーレンはCn(nはフラーレンを構成する炭素数)であればよく、好ましくはn=60以上100万以下の整数であり、好ましくはC60、C70がよい。また、本発明で使用されるフラーレンはフラーレンのエステル誘導体及びフラーレンが単数又は複数の酸素分子によって結合された誘導体でも良く、アルカリ金属、アルカリ土類金属から選択される金属塩でも良く、フラーレンのPVP等の水溶性高分子から選択される複合物であっても良い。これらの抗酸化物質は脂溶性物質であることが望ましいが、単体で脂溶性を示さなくても良く、例えば脂溶性の誘導体、又は脂溶性物質との複合物、又は脂溶性物質との複合体の一種以上の単体又は混合物等の形態を取ることにより脂溶性物質の分散体となっていても良い。 Applications of the nanocapsules of the present invention include pharmaceuticals, pharmaceutical raw materials, cosmetics, cosmetic raw materials, external preparations, ion introduction compositions, vibration introduction compositions, electromagnetic wave introduction compositions, heat introduction compositions, and electrolysis introduction compositions. In the case of foods, food additives, functional foods, feeds, feed additives, anti-aging agents, antioxidants and antioxidants, the fat-soluble substances of the present invention and claim 1 are preferably anti-fouling substances. More preferably, it is an antioxidant having radical scavenging effects such as singlet oxygen, hydroxy radical, NO radical, lipid peroxide, and more specifically vitamin C, vitamin E, vitamin A, coenzyme, Antioxidant derivative or provita which is one or more of a fat-soluble substance or a fat-soluble derivative selected from fullerene, lipoic acid and polyphenol It may be a down. The fullerene used in the present invention may be Cn (n is the number of carbon atoms constituting the fullerene), preferably n is an integer of 60 to 1,000,000, preferably C60 and C70. The fullerene used in the present invention may be an ester derivative of fullerene and a derivative in which fullerene is bonded by one or more oxygen molecules, or a metal salt selected from alkali metals and alkaline earth metals. It may be a composite selected from water-soluble polymers such as These antioxidant substances are desirably fat-soluble substances, but may not be fat-soluble alone, for example, fat-soluble derivatives, or complexes with fat-soluble substances, or complexes with fat-soluble substances. It may be a dispersion of a fat-soluble substance by taking the form of one or more simple substances or a mixture thereof.
本発明のナノカプセルの用途としては、医薬品、医薬品原料、化粧品、化粧品原料、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、食品、食品添加物、機能性食品,飼料、飼料添加物、老化防止剤、酸化防止剤、抗酸化剤から選択される一種以上の単体又は混合物であればよい。 Applications of the nanocapsules of the present invention include pharmaceuticals, pharmaceutical raw materials, cosmetics, cosmetic raw materials, external preparations, ion introduction compositions, vibration introduction compositions, electromagnetic wave introduction compositions, heat introduction compositions, and electrolysis introductions. It may be one or more simple substances or mixtures selected from compositions, foods, food additives, functional foods, feeds, feed additives, antioxidants, antioxidants and antioxidants.
本発明のナノカプセルの用途が、医薬品、医薬品原料、化粧品、化粧品原料、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、食品、食品添加物、機能性食品,飼料、飼料添加物、老化防止剤、酸化防止剤、抗酸化剤から選択される一種以上の単体又は混合物の場合の生理活性を有する脂溶性物質の添加量は、最終製剤の全重量に対して0.005%から90%重量の範囲で添加されていればよい。90%以上になるとカプセルを製造することが困難になり0.005%以下では効果が低下するためである。 Applications of the nanocapsules of the present invention include pharmaceuticals, pharmaceutical raw materials, cosmetics, cosmetic raw materials, external preparations, ion introduction compositions, vibration introduction compositions, electromagnetic wave introduction compositions, thermal introduction compositions, and electrolysis introduction compositions. Of fat-soluble substances having physiological activity in the case of one or more simple substances or mixtures selected from foods, foods, food additives, functional foods, feeds, feed additives, antioxidants, antioxidants, antioxidants The addition amount may be added in the range of 0.005% to 90% by weight with respect to the total weight of the final preparation. This is because it becomes difficult to produce capsules when it is 90% or more, and the effect is lowered when it is 0.005% or less.
本発明のナノカプセルの用途が、医薬品、医薬品原料、化粧品、化粧品原料、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、食品、食品添加物、機能性食品,飼料、飼料添加物、老化防止剤、酸化防止剤、抗酸化剤から選択される一種以上の単体又は混合物の場合の人又は生物への添加量は、生理活性を有する脂溶性物質の種類により異なるが、生理活性を有する脂溶性物質の効果発現量を含有するナノカプセルを生理的に許容される範囲内で投与、塗布、添加すれば良く、具体的にはナノカプセル量として体重1kgの人や生物に換算して300ppb〜10g/dayであればよい。 Applications of the nanocapsules of the present invention include pharmaceuticals, pharmaceutical raw materials, cosmetics, cosmetic raw materials, external preparations, ion introduction compositions, vibration introduction compositions, electromagnetic wave introduction compositions, thermal introduction compositions, and electrolysis introduction compositions. Food, food additives, functional foods, feed, feed additives, anti-aging agents, antioxidants, antioxidants, antioxidants, one or more selected from a single substance or mixture is added to humans or organisms Depending on the type of fat-soluble substance having physiological activity, nanocapsules containing the manifestation of the effect of the fat-soluble substance having physiological activity may be administered, applied, and added within the physiologically acceptable range. Specifically, the amount of nanocapsules may be 300 ppb to 10 g / day in terms of 1 kg body weight or a living organism.
本発明のナノカプセルの用途が、医薬品、医薬品原料、化粧品、化粧品原料、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、食品、食品添加物、機能性食品,飼料、飼料添加物、老化防止剤、酸化防止剤、抗酸化剤から選択される一種以上の単体又は混合物の場合、以下の生理学的に許容される剤形で製剤化する事ができる。 Applications of the nanocapsules of the present invention include pharmaceuticals, pharmaceutical raw materials, cosmetics, cosmetic raw materials, external preparations, ion introduction compositions, vibration introduction compositions, electromagnetic wave introduction compositions, thermal introduction compositions, and electrolysis introduction compositions. In the case of one or more simple substances or mixtures selected from foods, foods, food additives, functional foods, feeds, feed additives, antioxidants, antioxidants and antioxidants, the following physiologically acceptable Can be formulated in dosage form.
本発明、請求項2のナノカプセルの製剤化や安定化のためには、pHが1から13であればよい。In order to formulate and stabilize the nanocapsules of the present invention and claim 2, the pH may be 1 to 13.
また、本発明のナノカプセルの用途が、医薬品、医薬品原料、化粧品、化粧品原料、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、食品、食品添加物、機能性食品,飼料、飼料添加物、老化防止剤、酸化防止剤、抗酸化剤から選択される一種以上の単体又は混合物の場合、それらの具体的な効果としては、美白、色素沈着の改善、ニキビの治療、シワの改善、肌荒れの改善、油肌の改善、乾燥肌の改善、毛穴の縮小、瘢痕の治療、赤ら顔の治療、抜け毛の治療、育毛促進、やけどの治療、皮膚の殺菌、皮膚の殺ダニ、皮膚のキメの改善に対して治療効果を持つことができる。In addition, the use of the nanocapsule of the present invention includes pharmaceuticals, pharmaceutical raw materials, cosmetics, cosmetic raw materials, external preparations, ion introduction compositions, vibration introduction compositions, electromagnetic wave introduction compositions, thermal introduction compositions, electrolytic introductions. In the case of one or more simple substances or mixtures selected from compositions for foods, foods, food additives, functional foods, feeds, feed additives, antioxidants, antioxidants, antioxidants, their specific effects As whitening, pigmentation improvement, acne treatment, wrinkle improvement, rough skin improvement, oily skin improvement, dry skin improvement, pore reduction, scar treatment, red face treatment, hair loss treatment, hair growth promotion Can have a therapeutic effect on burn treatment, skin sterilization, skin mite killing, skin texture improvement.
また、これらの効果を得るのに必要な本発明のナノカプセルの濃度は、ナノカプセル又はその包接物の濃度等によって異なるが、0.1ppm〜100%重量であればよい。この100%重量とは請求項2のナノカプセルの原体そのものを最終製剤として処方する事もできる。但し使用感を考慮すると製剤中のナノカプセルの濃度が0.001〜50%重量が好ましい。この濃度で請求項2のナノカプセルの生体への添加量は皮膚に塗布する場合は皮膚面積1平方cm当たり0.01mgから10gであり、経口や注射などにより投与する場合は、体重60kg当たり0.01mgから100gであればよい。Moreover, although the density | concentration of the nanocapsule of this invention required in order to acquire these effects changes with the density | concentrations etc. of a nanocapsule or its clathrate, what is necessary is just 0.1 ppm-100% weight. With this 100% weight, the original nanocapsule itself of claim 2 can be formulated as a final preparation. However, considering the usability, the concentration of nanocapsules in the preparation is preferably 0.001 to 50% by weight. At this concentration, the nanocapsule of claim 2 is added to the body in an amount of 0.01 mg to 10 g per square centimeter of skin area when applied to the skin, and 0 or less per 60 kg of body weight when administered by oral or injection. It may be from 0.01 mg to 100 g.
本発明のナノカプセルは、常法に従い、種々の形態の基剤に配合して調製することもできる。例えば、液状、乳液液、クリーム状、粉状、軟膏状、分散液状、多層状、ペースト状、ゲル状、固形状、粉末状、ペレット状、顆粒状、カプセル状等種々の形態を選択することができる。The nanocapsules of the present invention can be prepared by blending with various forms of bases in accordance with conventional methods. For example, selecting various forms such as liquid, emulsion, cream, powder, ointment, dispersed liquid, multilayer, paste, gel, solid, powder, pellet, granule, capsule, etc. Can do.
又、本発明のナノカプセルは、常法に従い、外用組成物として知られる種々の形態の基剤に配合して調製することもできる。例えば、乳液、クリーム、化粧水、美容液、パック、オイル、ネイルケアプロダクト、リップクリーム、育毛剤、養毛剤、入浴剤、制汗剤等の基礎化粧料、シャンプー、リンス等の洗顔料や全身洗浄料、ファンデーション、白粉、メーキャップ用下地等のメーキャップ化粧料、軟膏、分散液等の外用医薬品等とすることができ、液状、多層状、乳液状、ペースト状、ゲル状、固形状、粉末状、顆粒状等種々の形態を選択することができる。The nanocapsules of the present invention can also be prepared by blending with various forms of bases known as compositions for external use according to a conventional method. For example, basic cosmetics such as milky lotion, cream, lotion, cosmetic liquid, pack, oil, nail care product, lip balm, hair restorer, hair nourishing agent, bathing agent, antiperspirant, facial cleanser such as shampoo, rinse, and whole body cleanser , Foundation, white powder, makeup cosmetics such as makeup base, ointments, dispersions, etc., liquid, multilayer, emulsion, paste, gel, solid, powder, granule Various forms such as a shape can be selected.
また、本発明のナノカプセルを含有する組成物及び請求項5の抗酸化物質の複合体には、上記各成分以外に、本発明の効果を損なわない範囲で、各種製剤に使用される成分、すなわち水(精製水、温泉水、深層水等)、油剤、界面活性剤、金属セッケン、ゲル化剤、粉体、アルコール類、水溶性高分子、皮膜形成剤、樹脂、包接化合物、保湿剤、抗菌剤、香料、消臭剤、塩類、PH調整剤、清涼剤、動物・微生物由来抽出物、植物抽出物、ビタミン類、アミノ酸類、核酸、ホルモン類、細胞賦活剤、血行促進剤、収斂剤、抗脂漏剤、活性酸素消去剤、角質溶解剤、酵素等を適宜一種又は二種以上を0.001から90%重量の範囲でさらに好ましくは0.01から50%重量の範囲で添加することができる。In addition, the composition containing the nanocapsules of the present invention and the complex of the antioxidant substance according to claim 5 are components used for various preparations in addition to the above-mentioned components, as long as the effects of the present invention are not impaired. That is, water (purified water, hot spring water, deep layer water, etc.), oil agent, surfactant, metal soap, gelling agent, powder, alcohol, water-soluble polymer, film forming agent, resin, clathrate compound, moisturizer , Antibacterial agents, fragrances, deodorants, salts, pH adjusters, refreshing agents, animal / microbe-derived extracts, plant extracts, vitamins, amino acids, nucleic acids, hormones, cell activators, blood circulation promoters, convergence 1 type or 2 types or more of additives, anti-seborrheic agents, active oxygen scavengers, keratolytic agents, enzymes, etc. are added in the range of 0.001 to 90% by weight, more preferably in the range of 0.01 to 50% by weight. can do.
上記記載の本発明のナノカプセルを含有する組成物に添加できる油剤及び請求項5の抗酸化物質の複合体としては、通常の化粧料に使用されるものであれば、天然系油であるか、合成油であるか、或いは、固体、半固体、液体であるか等の性状は問わず、炭化水素類、ロウ類、脂肪酸類、高級アルコール類、エステル油、シリコーン油類、フッ素系油類等、いずれの油剤も使用することができる。例えば、オゾケライト、スクワラン、スクワレン、セレシン、パラフィン、パラフィンワックス、流動パラフィン、プリスタン、ポリイソブチレン、マイクロクリスタリンワックス、ワセリン等の炭化水素類、ミツロウ、カルナウバロウ、キャンデリラロウ、鯨ロウ等のロウ類、牛脂、牛脚脂、牛骨脂、硬化牛脂、硬化油、タートル油、豚脂、馬脂、ミンク油、肝油、卵黄油等の動物油、ラノリン、液状ラノリン、還元ラノリン、ラノリンアルコール、硬質ラノリン、酢酸ラノリン、ラノリン脂肪酸イソプロピル、リン脂質、ホスファジルコリン、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテル等のラノリン誘導体、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸、オレイン酸、リノール酸、アラキドン酸、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)、イソステアリン酸、12−ヒドロキシステアリン酸等の脂肪酸類、ラウリルアルコール、ミリスチルアルコール、パルミチルアルコール、ステアリルアルコール、ベヘニルアルコール、ヘキサデシルアルコール、オレイルアルコール、イソステアリルアルコール、ヘキシルドデカノール、オクチルドデカノール、セトステアリルアルコール−2−デシルテトラデシノール、コレステロール、フィトステロール、シトステロール、ラノステロール、POEコレステロールエーテル、モノステアリルグリセリンエーテル(バチルアルコール)等の高級アルコール、アジピン酸ジイソブチル、アジビン酸2−ヘキシルデシル、アジピン酸ジ−2−ヘプチルウンデシル、モノイソステアリン酸N−アルキルグリコール、イソステアリン酸イソセチル、トリイソステアリン酸トリメチロールプロパン、ジ−2−エチルヘキサン酸エチレングリコール−2−エチルヘキサン酸セチル、トリ−2−エチルヘキサン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタエリスリトール、オクタン酸セチル、オクチルドデシルガムエステル、オレイン酸オレイル、オレイン酸オクチルドデシル、オレイン酸デシル、ジカプリン酸ネオペンチルグリコール、クエン酸トリエチル、コハク酸2−エチルヘキシル、酢酸アミル、酢酸エチル、酢酸ブチル、ステアリン酸イソセチル、ステアリン酸ブチル、セバシン酸ジイソプロピル、セバシン酸ジ−2−エチルヘキシル、乳酸セチル、乳酸ミリスチル、パルミチン酸イソプロピル、パルミチン酸2−エチルヘキシル、パルミチン酸2−ヘキシルデシル、パルミチン酸2−ヘプチルウンデシル、12−ヒドロキシステアリル酸コレステリル、ジペンタエリスリトール脂肪酸エステル、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、ミリスチン酸2−ヘキシルデシル、ミリスチン酸ミリスチル、ジメチルオクタン酸ヘキシルデシル、ラウリン酸エチル、ラウリン酸ヘキシル、N−ラウロイル−L−グルタミン酸2−オクチルドデシルエステル、リンゴ酸ジイソステアリル等のエステル油、アセトグリセライド、トリイソオクタン酸グリセライド、トリイソステアリン酸グリセライド、トリイソパルミチン酸グリセライド、トリ−2−エチルヘキサン酸グリセライド、モノステアリン酸グリセライド、ジ−2−ヘプチルウンデカン酸グリセライド、トリミリスチン酸グリセライド等のグリセライド油、ジメチルポリシロキサン、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、テトラメチルテトラハイドロジェンシクロテトラシロキサン、ステアロキシシリコーン等の高級アルコキシ変性シリコーン、高級脂肪酸変性シリコーン、シリコーン樹脂、シリコンゴム、シリコーンレジン等のシリコーン油、パーフルオロポリエーテル、パーフルオロデカリン、パーフルオロオクタン等のフッ素系油剤が挙げられる。The oil agent that can be added to the composition containing the nanocapsules of the present invention described above and the complex of the antioxidant substance according to claim 5 are natural oils if used in normal cosmetics. , Hydrocarbons, waxes, fatty acids, higher alcohols, ester oils, silicone oils, fluorine oils, regardless of whether they are synthetic oils or solid, semi-solid, liquid Any oil agent can be used. For example, hydrocarbons such as ozokerite, squalane, squalene, ceresin, paraffin, paraffin wax, liquid paraffin, pristane, polyisobutylene, microcrystalline wax, petroleum jelly, waxes such as beeswax, carnauba wax, candelilla wax, whale wax, beef fat , Beef leg fat, beef bone fat, hardened beef fat, hardened oil, turtle oil, pork fat, horse fat, mink oil, liver oil, egg yolk oil and other animal oils, lanolin, liquid lanolin, reduced lanolin, lanolin alcohol, hard lanolin, acetic acid Lanolin derivatives such as lanolin, lanolin fatty acid isopropyl, phospholipid, phosphadylcholine, POE lanolin alcohol ether, POE lanolin alcohol acetate, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, lauric Fatty acids such as acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid, oleic acid, linoleic acid, arachidonic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), isostearic acid, 12-hydroxystearic acid Lauryl alcohol, myristyl alcohol, palmityl alcohol, stearyl alcohol, behenyl alcohol, hexadecyl alcohol, oleyl alcohol, isostearyl alcohol, hexyl decanol, octyldodecanol, cetostearyl alcohol-2-decyltetradecinol, cholesterol, phytosterol , Sitosterol, lanosterol, POE cholesterol ether, monostearyl glycerol ether (batyl alcohol), etc. Coal, diisobutyl adipate, 2-hexyldecyl adipate, di-2-heptylundecyl adipate, N-alkyl glycol monoisostearate, isocetyl isostearate, trimethylolpropane triisostearate, ethylene di-2-ethylhexanoate Glycol-2-ethylhexanoate cetyl, tri-2-ethylhexanoate trimethylolpropane, tetra-2-ethylhexanoate pentaerythritol, cetyl octoate, octyldodecyl gum ester, oleic oleate, octyldodecyl oleate, oleic acid Decyl, neopentyl glycol dicaprate, triethyl citrate, 2-ethylhexyl succinate, amyl acetate, ethyl acetate, butyl acetate, isocetyl stearate, butyl stearate, Diisopropyl sebacate, di-2-ethylhexyl sebacate, cetyl lactate, myristyl lactate, isopropyl palmitate, 2-ethylhexyl palmitate, 2-hexyldecyl palmitate, 2-heptyl undecyl palmitate, cholesteryl 12-hydroxystearylate, Dipentaerythritol fatty acid ester, isopropyl myristate, octyldodecyl myristate, 2-hexyldecyl myristate, myristyl myristate, hexyldecyl dimethyloctanoate, ethyl laurate, hexyl laurate, 2-octyl N-lauroyl-L-glutamate Ester oil such as dodecyl ester, diisostearyl malate, acetoglyceride, triisooctanoic acid glyceride, triisostearic acid glyceride, Glyceride oil such as glyceride of lysopalmitic acid, glyceride of tri-2-ethylhexanoic acid, glyceride of monostearic acid, glyceride of di-2-heptylundecanoic acid, glyceride of trimyristic acid, dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogen Higher alkoxy-modified silicones such as polysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, tetramethyltetrahydrogencyclotetrasiloxane, stearoxysilicone, higher fatty acid-modified silicone, silicone resin, silicone rubber Silicone oil such as silicone resin, perfluoropolyether, perfluorodecalin, perfluorooctane Motokei oil and the like.
本発明のナノカプセルを含有する組成物及び請求項5の抗酸化物質の複合体に添加できる界面活性剤としては、アニオン性、カチオン性、非イオン性及び両性の活性剤があるが、本発明では非イオン界面活性剤が使用できる。
本発明のナノカプセルを含有する組成物及び請求項5の抗酸化物質の複合体に添加できるアニオン性界面活性剤としては、ステアリン酸ナトリウムやパルミチン酸トリエタノールアミン等の脂肪酸セッケン、アルキルエーテルカルボン酸及びその塩、アミノ酸と脂肪酸の縮合等のカルボン酸塩、アルキルスルホン酸、アルケンスルホン酸塩、脂肪酸エステルのスルホン酸塩、脂肪酸アミドのスルホン酸塩、アルキルスルホン酸塩とそのホルマリン縮合物のスルホン酸塩、アルキル硫酸エステル塩、第二級高級アルコール硫酸エステル塩、アルキル及びアリルエーテル硫酸エステル塩、脂肪酸エステルの硫酸エステル塩、脂肪酸アルキロールアミドの硫酸エステル塩、ロート油等の硫酸エステル塩類、アルキルリン酸塩、エーテルリン酸塩、アルキルアリルエーテルリン酸塩、アミドリン酸塩、N−アシルアミノ酸系活性剤等;カチオン性界面活性剤としては、アルキルアミン塩、ポリアミン及びアミノアルコール脂肪酸誘導体等のアミン塩、アルキル四級アンモニウム塩、芳香族四級アンモニウム塩、ピリジウム塩、イミダゾリウム塩等;非イオン性界面活性剤としては、ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ポリエチレングリコール脂肪酸エステル、ショ糖脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシプロピレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビトール脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンプロピレングリコール脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンフィトスタノールエーテル、ポリオキシエチレンフィトステロールエーテル、ポリオキシエチレンコレスタノールエーテル、ポリオキシエチレンコレステリルエーテル、ポリオキシアルキレン変性オルガノポリシロキサン、ポリオキシアルキレン・アルキル共変性オルガノポリシロキサン、アルカノールアミド、糖エーテル、糖アミド等;両性界面活性剤としては、ベタイン、アミノカルボン酸塩、イミダゾリン誘導体等が挙げられるがこれらに限定されない。Surfactants that can be added to the composition containing the nanocapsules of the present invention and the antioxidant complex of claim 5 include anionic, cationic, nonionic and amphoteric active agents. Then, a nonionic surfactant can be used.
Examples of the anionic surfactant that can be added to the composite comprising the nanocapsule of the present invention and the antioxidant substance of claim 5 include fatty acid soaps such as sodium stearate and triethanolamine palmitate, and alkyl ether carboxylic acids. And salts thereof, carboxylates such as condensation of amino acids and fatty acids, alkyl sulfonic acids, alkene sulfonates, sulfonates of fatty acid esters, sulfonates of fatty acid amides, sulfonates of alkyl sulfonates and their formalin condensates Salts, alkyl sulfates, secondary higher alcohol sulfates, alkyl and allyl ether sulfates, fatty acid ester sulfates, fatty acid alkylolamide sulfates, sulfate oils such as funnel oil, alkyl phosphorus Acid salt, ether phosphate, Kill allyl ether phosphate, amide phosphate, N-acyl amino acid type activator, etc .; cationic surfactants include alkylamine salts, amine salts such as polyamine and amino alcohol fatty acid derivatives, alkyl quaternary ammonium salts, aromatic Non-ionic surfactants include sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, propylene glycol fatty acid ester, polyethylene glycol fatty acid ester, sucrose fatty acid ester , Polyoxyethylene alkyl ether, polyoxypropylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester Polyoxyethylene sorbitol fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene propylene glycol fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene phytostanol ether, polyoxyethylene phytosterol ether, Polyoxyethylene cholestanol ether, polyoxyethylene cholesteryl ether, polyoxyalkylene-modified organopolysiloxane, polyoxyalkylene / alkyl co-modified organopolysiloxane, alkanolamide, sugar ether, sugar amide, etc .; as an amphoteric surfactant, betaine , Aminocarboxylates, imidazoline derivatives, and the like, but are not limited thereto.
本発明のナノカプセルを含有する組成物及び請求項5の抗酸化物質の複合体に添加できる金属セッケンとしては、12−ヒドロキシステアリン酸アルミニウム、ステアリン酸亜鉛、ステアリン酸アルミニウム、ステアリン酸カルシウム、ステアリン酸マグネシウム、ミリスチン酸亜鉛、ミリスチン酸マグネシウム、セチルリン酸亜鉛、セチルリン酸カルシウム、セチルリン酸亜鉛ナトリウム、ラウリン酸亜鉛、ウンデシレン酸亜鉛等が挙げられる。Metal soaps that can be added to the composite comprising the nanocapsules of the present invention and the antioxidant complex of claim 5 include 12-hydroxy aluminum stearate, zinc stearate, aluminum stearate, calcium stearate, magnesium stearate Zinc myristate, magnesium myristate, zinc cetyl phosphate, calcium cetyl phosphate, sodium cetyl phosphate, zinc laurate, zinc undecylenate and the like.
本発明のナノカプセルを含有する組成物及び請求項5の抗酸化物質の複合体に添加できるゲル化剤としては、N−ラウロイル−L−グルタミン酸、α,γ−ジ−n−ブチルアミン等のアミノ酸誘導体、デキストリンパルミチン酸エステル、デキストリンステアリン酸エステル、デキストリン2−エチルヘキサン酸パルミチン酸エステル等のデキストリン脂肪酸エステル、ショ糖パルミチン酸エステル、ショ糖ステアリン酸エステル等のショ糖脂肪酸エステル、モノベンジリデンソルビトール、ジベンジリデンソルビトール等のソルビトールのベンジリデン誘導体、ジメチルベンジルドデシルアンモニウムモンモリロナイトクレー、ジメチルジオクタデシルアンモニウムモンモリロナイトクレー等の有機変性粘土鉱物等が挙げられる。Examples of the gelling agent that can be added to the composite comprising the nanocapsule of the present invention and the antioxidant substance of claim 5 include amino acids such as N-lauroyl-L-glutamic acid and α, γ-di-n-butylamine. Derivatives, dextrin palmitate, dextrin stearate, dextrin fatty acid ester such as dextrin 2-ethylhexanoic acid palmitate, sucrose fatty acid ester such as sucrose palmitate, sucrose stearate, monobenzylidene sorbitol, di Examples include benzylidene derivatives of sorbitol such as benzylidene sorbitol, organically modified clay minerals such as dimethylbenzyl dodecyl ammonium montmorillonite clay and dimethyl dioctadecyl ammonium montmorillonite clay.
本発明のナノカプセルを含有する組成物に添加できる粉体及び請求項5の抗酸化物質の複合体としては、通常の製剤化に使用されるものであれば、その形状(球状、針状、板状、等)や粒子径(煙霧状、微粒子、顔料級等)、粒子構造(多孔質、無孔質等)を問わず、いずれのものも使用することができ、例えば、本発明のナノカプセルを含有する組成物に添加できる無機粉体としては、酸化マグネシウム、硫酸バリウム、硫酸カルシウム、硫酸マグネシウム、炭酸カルシウム、炭酸マグネシウム、タルク、合成雲母、マイカ、カオリン、セリサイト、白雲母、合成雲母、金雲母、紅雲母、黒雲母、リチア雲毋、ケイ酸、無水ケイ酸、ケイ酸アルミニウム、ケイ酸マグネシウム、ケイ酸アルミニウムマグネシウム、ケイ酸カルシウム、ケイ酸バリウム、ケイ酸ストロンチウム、タングステン酸金属塩、ヒドロキシアパタイト、バーミキュライト、ハイジライト、モンモリロナイト、ゼオライト、セラミックスパウダー、第二リン酸カルシウム、アルミナ、水酸化アルミニウム、窒化ホウ素、窒化ボロン等;有機粉体としては、ポリアミドパウダー、ポリエステルパウダー、ポリエチレンパウダー、ポリプロピレンパウダー、ポリスチレンパウダー、ポリウレタン、ベンゾグアナミンパウダー、ポリメチルベンゾグアナミンパウダー、テトラフルオロエチレンパウダー、ポリメチルメタクリレートパウダー、セルロース、シルクパウダー、ナイロンパウダー、12ナイロン、6ナイロン、スチレン・アクリル酸共重合体、ジビニルベンゼン・スチレン共重合体、ビニル樹脂、尿素樹脂、フェノール樹脂、フッ素樹脂、ケイ素樹脂、アクリル樹脂、メラミン樹脂、エポキシ樹脂、ポリカーボネイト樹脂、微結晶繊維粉体、ラウロイルリジン等;有色顔料としては、酸化鉄、水酸化鉄、チタン酸鉄の無機赤色顔料、γー酸化鉄等の無機褐色系顔料、黄酸化鉄、黄土等の無機黄色系顔料、黒酸化鉄、カーボンブラック等の無機黒色顔料、マンガンバイオレット、コバルトバイオレット等の無機紫色顔料、水酸化クロム、酸化クロム、酸化コバルト、チタン酸コバルト等の無機緑色顔料、紺青、群青等の無機青色系顔料、タール系色素をレーキ化したもの、天然色素をレーキ化したもの、及びこれらの粉体を複合化した複合粉体等;パール顔料としては、酸化チタン被覆雲母、酸化チタン被覆マイカ、オキシ塩化ビスマス、酸化チタン被覆オキシ塩化ビスマス、酸化チタン被覆タルク、魚鱗箔、酸化チタン被覆着色雲母等;金属粉末顔料としては、アルミニウムパウダー、カッパーパウダー、ステンレスパウダー等;タール色素としては、赤色3号、赤色104号、赤色106号、赤色201号、赤色202号、赤色204号、赤色205号、赤色220号、赤色226号、赤色227号、赤色228号、赤色230号、赤色401号、赤色505号、黄色4号、黄色5号、黄色202号、黄色203号、黄色204号、黄色401号、青色1号、青色2号、青色201号、青色404号、緑色3号、緑色201号、緑色204号、緑色205号、橙色201号、橙色203号、橙色204号、橙色206号、橙色207号等;天然色素としては、カルミン酸、ラッカイン酸、カルサミン、ブラジリン、クロシン等から選ばれる粉体で、これらの粉体を複合化したり、油剤やシリコーン、又はフッ素化合物で表面処理を行なった粉体でも良い。As a complex of the powder that can be added to the composition containing the nanocapsules of the present invention and the antioxidant substance of claim 5, the shape (spherical, needle-like, Any one can be used regardless of the plate shape, etc.), particle size (smoke, fine particles, pigment grade, etc.) and particle structure (porous, nonporous, etc.). Examples of inorganic powders that can be added to the capsule-containing composition include magnesium oxide, barium sulfate, calcium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, talc, synthetic mica, mica, kaolin, sericite, muscovite, and synthetic mica. , Phlogopite, red mica, biotite, lithia mica, silicic acid, anhydrous silicic acid, aluminum silicate, magnesium silicate, magnesium aluminum silicate, calcium silicate, silicic acid Lithium, strontium silicate, metal tungstate, hydroxyapatite, vermiculite, hydrite, montmorillonite, zeolite, ceramic powder, dicalcium phosphate, alumina, aluminum hydroxide, boron nitride, boron nitride, etc .; As organic powder, polyamide Powder, polyester powder, polyethylene powder, polypropylene powder, polystyrene powder, polyurethane, benzoguanamine powder, polymethylbenzoguanamine powder, tetrafluoroethylene powder, polymethyl methacrylate powder, cellulose, silk powder, nylon powder, 12 nylon, 6 nylon, styrene Acrylic acid copolymer, divinylbenzene / styrene copolymer, vinyl resin, urea resin Phenolic resin, fluororesin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, microcrystalline fiber powder, lauroyl lysine, etc .; As colored pigments, inorganic red pigments such as iron oxide, iron hydroxide, and iron titanate , Inorganic brown pigments such as γ-iron oxide, inorganic yellow pigments such as yellow iron oxide and loess, inorganic black pigments such as black iron oxide and carbon black, inorganic purple pigments such as manganese violet and cobalt violet, chromium hydroxide Inorganic green pigments such as chromium oxide, cobalt oxide and cobalt titanate, inorganic blue pigments such as bituminous and ultramarine blue, tar dyes raked, natural dyes raked, and composites of these powders Composite powders, etc .; pearl pigments include titanium oxide-coated mica, titanium oxide-coated mica, bismuth oxychloride, titanium oxide Covered bismuth oxychloride, titanium oxide coated talc, fish scale foil, titanium oxide coated colored mica, etc .; as metal powder pigment, aluminum powder, copper powder, stainless steel powder, etc .; as tar pigment, red No. 3, red No. 104, red 106, Red 201, Red 202, Red 204, Red 205, Red 220, Red 226, Red 227, Red 228, Red 230, Red 401, Red 505, Yellow 4 Yellow No. 5, Yellow No. 202, Yellow No. 203, Yellow No. 204, Yellow No. 401, Blue No. 1, Blue No. 2, Blue No. 201, Blue No. 404, Green No. 3, Green No. 201, Green No. 204, Green No. 205, Orange No. 201, Orange No. 203, Orange No. 204, Orange No. 206, Orange No. 207, etc .; natural pigments include carminic acid and lacaic acid Carthamine, brazilin, a powder selected from crocin, or composite of these powder, oil, silicone, or fluorine compound may be a powder was subjected to surface treatment.
本発明のナノカプセルを含有する組成物及び請求項5の抗酸化物質の複合体としてに添加できるアルコール類としては、エタノール、イソプロパノール等の低級アルコール、グリセリン、ジグリセリン、エチレングリコール、ジエチレングリコール、トリエチレングリコール、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ソルビトール、エリスリトール、マルチトール、マルトース、キシリトール、キシロース、トレハロース、イノシトール、グルコース、マンニトール、ポリエチレングリコール等の多価アルコール等がある。Examples of alcohols that can be added as a composite of the composition containing the nanocapsules of the present invention and the antioxidant substance of claim 5 include lower alcohols such as ethanol and isopropanol, glycerin, diglycerin, ethylene glycol, diethylene glycol, and triethylene. Examples include glycols, propylene glycol, dipropylene glycol, 1,3-butylene glycol, sorbitol, erythritol, maltitol, maltose, xylitol, xylose, trehalose, inositol, glucose, mannitol, and polyhydric alcohols such as polyethylene glycol.
本発明のナノカプセルを含有する組成物及び請求項5の抗酸化物質の複合体として添加できる水溶性高分子としては、コンドロイチン硫酸、ヒアルロン酸、ムチン、デルマタン硫酸、ヘパリン及びケラタン硫酸から選ばれるムコ多糖類及びその塩、アラビアゴム、トラガカント、ガラクタン、キャロブガム、グアーガム、カラヤガム、カラギーナン、ペクチン、寒天、クインスシード、アルゲコロイド、トラントガム、ローカストビーンガム、ガラクトマンナン等の植物系高分子、キサンタンガム、デキストラン、サクシノグルカン、プルラン等の微生物系高分子、コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系高分子、デンプン、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子、メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、カルボキシメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、ニトロセルロース、セルロース硫酸ナトリウム、カルボキシメチルセルロースナトリウム、結晶セルロース、セルロース末のセルロース系高分子、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高分子、ポリビニルメチルエーテル、カルボキシビニルポリマー、アルキル変性カルボキシビニルポリマー等のビニル系高分子、ポリオキシエチレン系高分子、ポリオキシエチレンポリオキシプロピレン共重合体系高分子、ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等のアクリル系高分子、ポリエチレンイミン、カチオンポリマー、ベントナイト、ラポナイト、ヘクトライト等の無機系水溶性高分子等がある。また、この中には、ポリビニルアルコールやポリビニルピロリドン等の皮膜形成剤も含まれる。The water-soluble polymer that can be added as a composite of the composition containing the nanocapsules of the present invention and the antioxidant substance of claim 5 is mucos selected from chondroitin sulfate, hyaluronic acid, mucin, dermatan sulfate, heparin and keratan sulfate. Polysaccharides and salts thereof, plant polymers such as gum arabic, tragacanth, galactan, carob gum, guar gum, caraya gum, carrageenan, pectin, agar, quince seed, algae colloid, tant gum, locust bean gum, galactomannan, xanthan gum, dextran, Microbial polymers such as succinoglucan and pullulan, animal polymers such as collagen, casein, albumin and gelatin; starch polymers such as starch, carboxymethyl starch and methylhydroxypropyl starch; Loose, ethylcellulose, methylhydroxypropylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxypropylcellulose, nitrocellulose, sodium cellulose sulfate, sodium carboxymethylcellulose, crystalline cellulose, cellulose-based cellulose polymer, sodium alginate, propylene glycol alginate, etc. Alginate polymer, polyvinyl methyl ether, carboxyvinyl polymer, vinyl polymer such as alkyl-modified carboxyvinyl polymer, polyoxyethylene polymer, polyoxyethylene polyoxypropylene copolymer polymer, sodium polyacrylate, poly Acrylic polymers such as ethyl acrylate and polyacrylamide, polyethyleneimine Cationic polymers, bentonite, laponite, and inorganic water-soluble polymers such as hectorite. Also included are film forming agents such as polyvinyl alcohol and polyvinyl pyrrolidone.
本発明のナノカプセルを含有する組成物に添加できる抗菌剤としては、安息香酸、安息香酸ナトリウム、サリチル酸、石炭酸、ソルビン酸、ソルビン酸カリウム、パラオキシ安息香酸エステル、パラクロルメタクレゾール、ヘキサクロロフェン、塩化ベンザルコニウム、塩化クロルヘキシジン、トリクロロカルバニリド、感光素、ビス(2−ピリジルチオ−1−オキシド)亜鉛、ペンタジオール、アイチュリン、サーファクチン、ポリグリシン、エタノール、フェノキシエタノール、イソプロピルメチルフェノール等が挙げられる。Antibacterial agents that can be added to the composition containing the nanocapsules of the present invention include benzoic acid, sodium benzoate, salicylic acid, carboxylic acid, sorbic acid, potassium sorbate, p-hydroxybenzoic acid ester, parachlorometacresol, hexachlorophene, chloride Benzalkonium, chlorhexidine chloride, trichlorocarbanilide, photosensitizer, bis (2-pyridylthio-1-oxide) zinc, pentadiol, iturin, surfactin, polyglycine, ethanol, phenoxyethanol, isopropylmethylphenol and the like can be mentioned.
本発明のナノカプセルを含有する組成物に添加できるPH調整剤としては、乳酸、クエン酸、グリコール酸、コハク酸、酒石酸、リンゴ酸、炭酸カリウム、炭酸水素ナトリウム、炭酸水素アンモニウム等、清涼剤としては、L−メントール、カンフル等が挙げられる。PH adjusters that can be added to the composition containing the nanocapsules of the present invention include lactic acid, citric acid, glycolic acid, succinic acid, tartaric acid, malic acid, potassium carbonate, sodium bicarbonate, ammonium bicarbonate, etc. Examples thereof include L-menthol and camphor.
本発明のナノカプセルを含有する組成物に添加できる動物由来及び微生物由来の抽出物としては、例えば、ブタ、ウシ等の血液抽出液、血清除蛋白抽出物、脾臓抽出物、トリの卵成分、鶏冠抽出物、魚肉抽出物、イカスミ、キチン、キトサン、貝殻抽出物、貝肉抽出物、ローヤルゼリー、シルクプロテイン及びその分解物又はそれらの誘導体、ヘモグロビン又はその分解物、牛乳、カゼイン及びその誘導体又はそれらの分解物、ラクトフェリン又はその分解物、コラーゲン及びその誘導体又はそれらの加水分解物、エラスチン及びその誘導体又はそれらの加水分解物、ケラチン及びその誘導体又はそれらの分解物等、哺乳類、鳥類、魚類、軟体動物類、甲殻類、貝類、昆虫類等の動物由来抽出物;酵母代謝物、醗酵代謝産物、酵母抽出物、乳酸菌抽出物、ビフィズス菌抽出物等の微生物由来の抽出物が挙げられる。Examples of animal-derived and microorganism-derived extracts that can be added to the composition containing the nanocapsules of the present invention include blood extracts such as pigs and cows, serum deproteinized extracts, spleen extracts, avian egg components, Chicken crown extract, fish extract, squid ink, chitin, chitosan, shell extract, shell extract, royal jelly, silk protein and its degradation product or derivatives thereof, hemoglobin or its degradation product, milk, casein and its derivatives or their derivatives Degradation products, lactoferrin or degradation products thereof, collagen and derivatives thereof or hydrolysis products thereof, elastin and derivatives thereof or hydrolysis products thereof, keratin and derivatives thereof or degradation products thereof, mammals, birds, fish, soft bodies Extracts from animals such as animals, crustaceans, shellfish, insects; yeast metabolites, fermentation metabolites, yeast extracts, milk Fungal extract, extracts from microorganisms such as bifidobacteria extract.
本発明のナノカプセルを含有する組成物に添加できる天然抽出物としては、グラブリジン、グラブレン、リクイリチン、イソリクイリチン及びこれらを含有するカンゾウ抽出物、胎盤抽出物、カロチノイド類及びこれらを含有する動植物抽出物、ネオアガロビオース、アガロースオリゴサッカライド、アスパラガス抽出物、イブキトラノオ抽出物、エンドウ豆抽出物、エイジツ抽出物、オウゴン抽出物、オノニス抽出物、海藻抽出物、キイチゴ抽出物、クジン抽出物、ケイケットウ抽出物、ゴカヒ抽出物、リノール酸を含有する植物油、サイシン抽出物、サンザシ抽出物、サンペンズ抽出物、シラユリ抽出物、シャクヤク抽出物、センプクカ抽出物、ソウハクヒ抽出物、大豆抽出物、茶抽出物、トウキ抽出物、糖蜜抽出物、ビャクレン抽出物、ブナノキ抽出物、ブドウ種子抽出物、フローデマニータ抽出物、ホップ抽出物、マイカイカ抽出物、モッカ抽出物、ユキノシタ抽出物、ヨクイニン抽出物及び羅漢果抽出物、アスパラガス、アカネ、アカブドウ、アカメガシワ、アケビ、アサ、アサガオ、アズキ、アセンヤク、アマチャ、アマチャヅル、イタドリ、イチジク、イチョウ、イランイラン、ウツボグサ、ウメ、ウワウルシ、ウンシュウミカン、エゾウコギ、エビスグサ、エンジュ、エンドウ、オオバコ、オクラ、オグルマ、オニグルミ、オミナエシ、オランダイチゴ、カキ、カキドウシ、カシュウ、カシュー、カノコソウ、カラスウリ、カリン、ガラナ、キキョウ、キク、キササゲ、ギシギシ、ギムネマ・シルベスタ、キンミズヒキ、グアバ、クコ、クズ、クスノキ、クリ、ケイケットウ、ゲッケイジュ、ケイヒ、ゴショイチゴ、コショウ、コーヒー、ゴマノハグサ、コロンボ、サザンカ、サンショウ、サフラン、サクラ、ザクロ、サンズコン、サンペンズ、シオン、ショウブ、スイカ、ステビア、スモモ、セイヨウキズタ、セイヨウナシ、セイヨウノコギリソウ、セイヨウネズ、セイヨウワサビ、セキショウ、セリ、セネガ、センナ、ダイオウ、ダイダイ、タマリンド、タラノキ、タンポポ、チコリ、チョウジ、チョウセンゴミシ、チョレイ、ツキミソウ、ツボクサ、ツユクサ、ツルナ、テウチグルミ、トウガン、トチュウ、トロロアオイ、ナズナ、ナツミカン、ナンテン、ニガキ、ノコギリソウ、パイナップル、ハイビスカス、パパイヤ、バジル、ハス、ハダカムギ、ヒオウギ、ピーナツ、ヒキオコシ、ヒシ、ピスタチオ、ヒバ、ヒメマツタケ、ビャクシ、ビワ、フキタンポポ、フシノキ、フジバカマ、ブルーベリー、ボウフウ、ホオズキ、ホオノキ、ボケ、マイカイ、マオウ、マンゴー、マンネンタケ、ミシマサイコ、ミソハギ、ミツバ、ミモザ、メリロート、メロン、モクレン、モモルディカ・グロスベノリィ、モロヘイヤ、モヤシ、ヤクチ、ヤクモソウ、ヤグルマソウ、ヤシ、ヤシャジツ、ヤドリギ、ヤナギタデ、ヤマゴボウ、ヤマモモ、ユズリハ、ヨモギ、ライムギ、ラン、リュウガン、リンゴ、レイシ、レンギョウ等が挙げられる。Natural extracts that can be added to the composition containing the nanocapsules of the present invention include glabrizine, glabrene, liquiritin, isoliquiritin and licorice extract containing these, placenta extract, carotenoids and animal and plant extracts containing these, Neo agarobiose, agarose oligosaccharide, asparagus extract, ibukitorano extract, pea extract, age extract, ougon extract, onionis extract, seaweed extract, raspberry extract, cucumber extract, caquette extract , Scallop extract, plant oil containing linoleic acid, saicin extract, hawthorn extract, sampens extract, shirayuri extract, peonies extract, sempukuka extract, sohakuhi extract, soybean extract, tea extract, toki Extract, molasses extract, beechlen extract Beech extract, grape seed extract, flow demanita extract, hop extract, micaika extract, mokka extract, yukinoshita extract, yokuinin extract and rahan fruit extract, asparagus, akane, red grape, akamegashiwa, akebi, Asa, morning glory, azuki bean, asenyak, achacha, amacha eel, itadori, fig, ginkgo, ylang ylang, moray eel, ume, cormorant, walrus, mandarin orange, prairie moth, shrimp, enju, pea, plantain, okra, ogurma, minced oak , Oysters, persimmons, cashews, cashews, valerian, calla lilies, quince, guarana, kyoto, chrysanthemum, catalpa, scallop, gymnema sylvesta, goldfish, guava, wolfberry, kudzu, camphor, chestnut Ketou, gecko, keihi, gosho strawberries, pepper, coffee, sesame seeds, colombo, sasanqua, salamander, saffron, cherry blossom, pomegranate, sandscon, sunpens, zion, shobu, watermelon, stevia, plum, swan, pear, psyllium, Horseshoe, horseradish, buffalo, buffalo, seri, senega, senna, daiou, daidai, tamarind, taranki, dandelion, chicory, clove, dung beetle, chorei, primrose, clover, communis, tsuruna, teuchigurumi, tougan, tochua, toruo Natsumikan, Nanten, Nigaki, Yarrow, Pineapple, Hibiscus, Papaya, Basil, Lotus, Hadakamugi, Hagi, Peanut, Hikikoshi, Hishi, Piss Tachio, Hiba, Himematsutake, Peacock, Biwa, Japanese dandelion, Fushinoki, Fujibakama, Blueberry, Bowfish, Physalis, Hoonoki, Bokeh, Maikai, Mao, Mango, Mannentake, Mishimasaiko, Misohagi, Mitsuba, Mimosa, Meriron, Memoron Examples include gross benoly, moroheiya, sprout, yakchi, yakusou, cornflower, palm, yashajitsu, mistletoe, willow, pokeweed, bayberry, quail, mugwort, rye, orchid, longan, apple, litchi and forsythia.
ビタミン類としては、リノレン酸及びその誘導体等のビタミンF類;フィトナジオン、メナキノン、メナジオン、メナジオール等のビタミンK類;エリオシトリン、ヘスペリジン等のビタミンP類;その他、ビオチン、カルチニン、フェルラ酸等が挙げられる。Examples of vitamins include vitamin Fs such as linolenic acid and its derivatives; vitamin Ks such as phytonadione, menaquinone, menadione and menadiol; vitamins P such as eriocitrin and hesperidin; other biotin, carcinine, ferulic acid and the like It is done.
本発明のナノカプセルを含有する組成物に添加できるアミノ酸類としては、グリシン、アラニン、バリン、イソロイシン、セリン、スレオニン、アスパラギン酸、グルタミン酸、アスパラギン、グルタミン、リジン、ヒドロキシリジン、アルギニン、シスチン、メチオニン、フェニルアラニン、チロシン、プロリン、ヒドロキシプロリン、オルチニン、シトルリン、テアニン等のアミノ酸及びそれらの誘導体並びにそれらの塩、あるいはピロリドンカルボン酸等のアミノ酸誘導体またはその誘導体等が挙げられる。核酸関連物質としては、デオキシリボ核酸及びその塩、アデノシン三リン酸、アデノシン二リン酸、アデノシン一リン酸から選ばれるアデニル酸誘導体及びそれらの塩、リボ核酸及びその塩、サイクリックAMP、サイクリックGMP、フラビンアデニンヌクレオチド、グアニン、アデニン、シトシン、チミン、キサンチン及びそれらの誘導体であるカフェイン、テオフィリン並びにそれらの塩、ホルモンとしては、エストラジオール、エテニルエストラジオール等が挙げられる。酵素としては、リパーゼ、パパイン等が挙げられる。Amino acids that can be added to the composition containing the nanocapsules of the present invention include glycine, alanine, valine, isoleucine, serine, threonine, aspartic acid, glutamic acid, asparagine, glutamine, lysine, hydroxylysine, arginine, cystine, methionine, Examples include amino acids such as phenylalanine, tyrosine, proline, hydroxyproline, ortinin, citrulline, and theanine, and derivatives thereof, salts thereof, amino acid derivatives such as pyrrolidone carboxylic acid, and derivatives thereof. Examples of nucleic acid-related substances include deoxyribonucleic acid and salts thereof, adenylic acid derivatives selected from adenosine triphosphate, adenosine diphosphate and adenosine monophosphate and salts thereof, ribonucleic acid and salts thereof, cyclic AMP, and cyclic GMP Examples of the flavin adenine nucleotide, guanine, adenine, cytosine, thymine, xanthine and their derivatives caffeine, theophylline, and salts and hormones thereof include estradiol, etenyl estradiol and the like. Examples of the enzyme include lipase and papain.
本発明のナノカプセルを含有する組成物に添加できる血行促進剤としては、ノニル酸ワレニルアミド、カプサイシン、ジンゲロン、カンタリスチンキ、イクタモール、α−ボルネオール、イノシトールヘキサニコチネート、シクランデレート、シンナリジン、トラゾリン、アセチルコリン、ベラパミル、セファランチン、γ−オリザノール等、皮膚収斂剤としては、タンニン酸等が挙げられ、抗脂漏剤としては、イオウ、チアントロール等があげられる。As a blood circulation promoter that can be added to the composition containing the nanocapsule of the present invention, nonyl acid wallenylamide, capsaicin, gingerone, cantalis tincture, ictamol, α-borneol, inositol hexanicotinate, cyclandrate, cinnarizine, trazoline, Examples of skin astringents such as acetylcholine, verapamil, cephalanthin, and γ-oryzanol include tannic acid, and examples of antiseborrheic agents include sulfur and thianthol.
ナノカプセル製造原料用組成物を化粧料の用途に使用する場合には、以下の任意成分を配合することもできる。When the composition for producing nanocapsules is used for cosmetics, the following optional components can be blended.
このような成分としては、例えば、ワセリン、マイクロクリスタリンワックス等の炭化水素類;ミリスチン酸オクチルドデシル、ミリスチン酸イソプロピル等のエステル類、トリイソオクタン酸グリセリル、オリーブ油等のトリグリセライド類;メチルフェニルポリシロキサン、メチルポリシロキサン等のシリコーン油類;セタノール、ベヘニルアルコール等の高級アルコール類、ステアリン酸、オレイン酸等の脂肪酸類;グリセリン、1,3−ブタンジオール、プロピレングリコール等の多価アルコール類;エタノール、イソプロピルアルコール等の低級アルコール類;非イオン界面活性剤、陰イオン界面活性剤、陽イオン界面活性剤、両性界面活性剤、増粘剤、紫外線吸収剤、酸化防止剤、エモリエント剤、乳化剤、可溶化剤、抗炎症剤、保湿剤、防腐剤、殺菌剤、pH調整剤、色素、香料、粉体類、水等が挙げられる。Examples of such components include hydrocarbons such as petrolatum and microcrystalline wax; esters such as octyldodecyl myristate and isopropyl myristate; glyceryl triisooctanoate and triglycerides such as olive oil; methylphenylpolysiloxane, methyl Silicone oils such as polysiloxane; higher alcohols such as cetanol and behenyl alcohol; fatty acids such as stearic acid and oleic acid; polyhydric alcohols such as glycerin, 1,3-butanediol, and propylene glycol; ethanol, isopropyl alcohol, etc. Lower alcohols: nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, thickeners, UV absorbers, antioxidants, emollients, emulsifiers, solubilizers, anti Inflammatory agent Humectants, preservatives, germicides, pH adjusting agents, dyes, perfumes, powders such as water and the like.
さらに本発明のナノカプセルを含有する組成物には、既存の原料規格書又は、公定書に記載された原料を一般的な濃度例えば好ましくは本発明のナノカプセルを含有する組成物の全体量に対して100ppm〜90%重量で添加することもできる。上記の既存の原料規格書又は、公定書に記載された原料とは、例えば、第十四改正日本薬局方、財団法人日本公定書協会編集、株式会社じほう発行、2001年4月発行、化粧品原料基準第二版注解、日本公定書教会編、1984(薬事日報社)、化粧品原料基準外成分規格、厚生省薬務局審査課監修、1993(薬事日報社)、化粧品原料基準外成分規格追補、厚生省薬務局審査課監修、1993(薬事日報社)、化粧品種別許可基準、厚生省薬務局審査課監修、1993(薬事日報社)、及びInternational Cosmetic Ingredient Dictionary and Handbook2002Ninth Edition Vol.1〜4,by CTFA、化粧品原料辞典平成3年(日光ケミカルズ)等に記載されている全ての原料を使用することができる。Furthermore, in the composition containing the nanocapsule of the present invention, the existing raw material specifications or the raw materials described in the official document are added to a general concentration, for example, preferably the total amount of the composition containing the nanocapsule of the present invention. It can also be added at 100 ppm to 90% by weight. Examples of the raw materials described in the above-mentioned existing raw material standards or official documents include, for example, the 14th revised Japanese Pharmacopoeia, edited by the Japan Standards Association, issued by Jiho Co., Ltd., issued in April 2001. Commentary on the second edition of the standards, edited by the Japanese Official Church, 1984 (Pharmaceutical Daily Report), Standards for Ingredients for Cosmetic Ingredients, Supervised by the Pharmaceutical Affairs Bureau, Ministry of Health and Welfare, 1993 (Pharmaceutical Daily Report), Supplement for Standards for Ingredients for Cosmetic Ingredients, Ministry of Health and Welfare Supervised by the Pharmaceutical Affairs Bureau Screening Division, 1993 (Pharmaceutical Daily Report), Permit Cosmetics Permit Standard, Ministry of Health and Welfare Pharmacy Screening Division Supervision, 1993 (Pharmaceutical Daily Report), and International Cosmetic Ingredient Dictionary 2002 Ninth Edition Vol. All raw materials described in 1-4, by CTFA, cosmetic raw material dictionary 1991 (Nikko Chemicals) and the like can be used.
本発明のナノカプセルは、イオン導入、振動導入、電磁波導入、温熱導入、電解導入から選択される一種以上の単法又は混合方法により導入する事により請求項6の用途の効果をいっそう高めることができる。The nanocapsule of the present invention can further enhance the effect of the application of claim 6 by introducing it by one or more single methods or mixing methods selected from ion introduction, vibration introduction, electromagnetic wave introduction, heat introduction, and electrolysis introduction. it can.
本発明、請求項2のナノカプセルの製造方法は、請求項1の組成物を水に分散することにより形成されればよく、本発明の請求項2のナノカプセルは、耐衝撃性で請求項1のナノカプセル製造原料用組成物を剪断変形にかけて製造することもできる。耐衝撃性は、請求項1のナノカプセル製造原料用組成物に対して一定の圧力以上の水流を衝突させることで容易に請求項2のナノカプセルを製造することができるが粒度分布範囲を狭める目的やナノカプセル粒子の平均粒子経を200nm以下にする場合は剪断変形を付加する装置を使用するのが好ましい。より好ましくは、ナノカプセル製造原料用組成物を少なくとも15/sの剪断速度で剪断変形にかけると、水及び水系溶剤に分散した平均粒子経1000nm未満の微小乳化粒子を製造することができる。ここで言う一定の圧力の水流とは特に特殊な加圧装置は必要なく水道水の水圧程度の圧力で充分である。又はタンクに貯蔵された請求項1のナノカプセル製造原料用組成物と水を通常の攪拌機で混合する程度の剪断速度でもよい。
剪断変形を付加する装置の具体例としては、攪拌機、攪拌ミル、攪拌ミキサー、ホモミキサー、スクリューミキサー、ドリルミキサー等があるが、より好ましくはスタティックミキサー、ジェットディスパゲーター、ミクロポーラスフィルター、マイクロフルイダイザー及びManton−Gaulinホモジェナイザーノズルから成る群から選ばれる少なくとも1種の分散装置を用いて行うこともできる。The nanocapsule production method of the present invention and claim 2 may be formed by dispersing the composition of claim 1 in water, and the nanocapsule of claim 2 of the present invention is impact resistant. One composition for producing nanocapsules can be produced by subjecting it to shear deformation. With respect to impact resistance, the nanocapsules of claim 2 can be easily produced by colliding a water flow at a certain pressure or higher against the composition for producing nanocapsules of claim 1, but the particle size distribution range is narrowed. When the purpose or the average particle size of the nanocapsule particles is set to 200 nm or less, it is preferable to use an apparatus for applying shear deformation. More preferably, when the composition for nanocapsule production raw material is subjected to shear deformation at a shear rate of at least 15 / s, fine emulsion particles having an average particle diameter of less than 1000 nm dispersed in water and an aqueous solvent can be produced. The water flow at a constant pressure here does not require a special pressurizing device, and a pressure of about the water pressure of tap water is sufficient. Or the shear rate of the grade which mixes the composition for nanocapsule manufacture raw materials of Claim 1 stored in the tank, and water with a normal stirrer may be sufficient.
Specific examples of the apparatus for applying shear deformation include a stirrer, a stirrer mill, a stirrer mixer, a homomixer, a screw mixer, and a drill mixer, and more preferably a static mixer, a jet displacer, a microporous filter, and a microfluidizer. And at least one disperser selected from the group consisting of Manton-Gaulin homogenizer nozzles.
また、圧力エネルギーを圧抜きノズル中で小体積物体中に消散させるジェットディスパゲーター(jet dispergator)を、本発明のナノカプセル製造装置として使用することができる。他の適切な静的分散装置の例として、ミクロポーラスフィルター、マイクロポーラスガラスフィルター、マイクロフルイダイザー(microfluidizer)及びManton−Gaulinホモジェナイザーノズルが挙げられる。ジェットディスパゲーターが好ましい装置である。A jet dispersator that dissipates pressure energy into a small volume object in a depressurizing nozzle can be used as the nanocapsule manufacturing apparatus of the present invention. Examples of other suitable static dispersion devices include microporous filters, microporous glass filters, microfluidizers and Manton-Gaulin homogenizer nozzles. A jet dispagator is a preferred device.
従って、本発明の一つの重要な特徴は、この発明の方法による剪断変形によって、ナノカプセルの平均粒子サイズ(本明細書では「dw」と表現)が減少し、そして粒子のサイズ分布の巾(本明細書では「dw/dn」と表現、ここでdnは数平均粒子サイズを示す)が狭くなるということに存する。本発明の方法に従って本発明で開示した速度で剪断変形をかけると、dwとdw/dnが、上記の速度で剪断応力をかけない方法によって得られる値を基準にして少なくとも20%、好ましくは30%減少する。Thus, one important feature of the present invention is that the shear deformation by the method of the present invention reduces the average particle size of nanocapsules (denoted herein as “d w ”) and the width of the particle size distribution. (expressed as "d w / d n", as used herein, wherein d n is the number average particle size) consists in that it becomes narrower. When applying a speed shear deformation disclosed in the present invention according to the methods of the present invention, d w and d w / d n is based on the value obtained by the method without shearing stresses above the speed at least 20%, Preferably it is reduced by 30%.
この剪断応力は、相反転が完了した後にかける。ジェットディスパゲーターは圧抜きノズルを持っており、そのノズルでは、利用できる圧力エネルギーが、分散領域において可能な限り小さい体積中で消散され、これを用いて高い容積比分散力が得られる。This shear stress is applied after the phase inversion is completed. The jet displacer has a depressurizing nozzle in which the available pressure energy is dissipated in the smallest possible volume in the dispersion region, which is used to obtain a high volumetric specific dispersion force.
適切なスタティックミキサーの例として、Sulzer社、Winterthur、スイス/ドイツ(商業識別SMX)から入手可能なミキサーが挙げられる。全てのスタチックミキサーの共通点は、管中での流体の流れが、内部の構成要素によって、絶え間なく分離され、再配置され、結合され、再分配されることである。スタティックミキサーは、それによってジェットディスパゲーターに似た方法で運転される、すなわち、利用できる圧力エネルギーが、スタティックミキサー中で消散される。Examples of suitable static mixers include those available from Sulzer, Winterthur, Switzerland / Germany (commercially identified SMX). The common point of all static mixers is that the fluid flow in the tube is constantly separated, rearranged, combined and redistributed by internal components. The static mixer is thereby operated in a manner similar to a jet dispersator, i.e. the available pressure energy is dissipated in the static mixer.
ナノカプセル粒子を含有する重合体溶液が剪断用装置を通して移送される容積流量は高く、0.01〜500バール、好ましくは0.5と50バールの間の圧力低下が現れる。0.5から50バールの操作圧は比較的シンプルで高価でないポンプで発生させることができる。剪断用装置中での剪断速度(速度勾配、剪断速度)は高く、少なくとも100/s、好ましくは1000から20000000/s、最も好ましくは35000から1500000/sである。この剪断速度は圧力低下により設定される。The volumetric flow rate at which the polymer solution containing the nanocapsule particles is transferred through the shearing device is high, and a pressure drop of between 0.01 and 500 bar, preferably between 0.5 and 50 bar appears. An operating pressure of 0.5 to 50 bar can be generated with a relatively simple and inexpensive pump. The shear rate (velocity gradient, shear rate) in the shearing apparatus is high, at least 100 / s, preferably 1000 to 20000000 / s, most preferably 35000 to 1500,000 / s. This shear rate is set by the pressure drop.
以下、実施例により本発明をさらに詳細に説明するが、本発明はこれら実施例になんら限定されるものではない。なお、以下で掲げるグリセリンは含量98質量%以上のものを使用した。また、サーファクチンナトリウムは昭和電工株式会社製アミノフェクト(昭和電工株式会社登録商標)を使用した。%は重量%である。EXAMPLES Hereinafter, although an Example demonstrates this invention further in detail, this invention is not limited to these Examples at all. The glycerin listed below was used with a content of 98% by mass or more. As Surfactin sodium, Aminofect (registered trademark of Showa Denko KK) manufactured by Showa Denko KK was used. % Is% by weight.
実施例1:ナノカプセル製造原料用組成物
グリセリン20質量部にサーファクチンナトリウム1質量部を溶解し、これにスクアラン2質量部を添加し均一になるまで撹拌しナノカプセル製造原料用組成物を作成した。Example 1: Composition for raw material for producing nanocapsules Dissolve 1 part by weight of surfactin sodium in 20 parts by weight of glycerin, add 2 parts by weight of squalane to this and stir until uniform to create a composition for raw materials for producing nanocapsules. did.
実施例2:
実施1のナノカプセル製造原料用組成物にスクアラン2質量部を添加し均一になるまで撹拌した。この操作を4回繰り返した。次いで、スクアラン4質量部を添加し均一になるまで撹拌した。この操作を5回繰り返した。次いで、スクアラン6質量部を添加し均一になるまで撹拌した。この操作を3回繰り返した。次いで、スクアラン8質量部を添加し均一になるまで撹拌した。この操作を4回繰り返し、ナノカプセル製造原料用組成物を得た。最終的な配合組成は、スクアラン80質量部グリセリン20質量部サーファクチンナトリウム1質量部であった。Example 2:
2 parts by mass of squalane was added to the composition for raw material for producing nanocapsules of Example 1 and stirred until uniform. This operation was repeated 4 times. Next, 4 parts by mass of squalane was added and stirred until uniform. This operation was repeated 5 times. Next, 6 parts by mass of squalane was added and stirred until uniform. This operation was repeated three times. Next, 8 parts by mass of squalane was added and stirred until uniform. This operation was repeated 4 times to obtain a composition for raw material for producing nanocapsules. The final composition was 80 parts by weight of squalane, 20 parts by weight of glycerin, and 1 part by weight of surfactin sodium.
実施例3:ナノカプセル用原料組成物
下記の処方でグリセリンにサーファクチンナトリウムを加えて溶解し、撹拌しながら以下の組成のオイル混合物を少量ずつ添加した。さらに撹拌しながら水、1,3−ブタンジオールをゆっくり添加し最終的にオイル混合物60%、グリセリン23%、1,3−ブタンジオール13%、水3%。サーファクチンナトリウム1%のナノカプセル用原料組成物を得た。Example 3: Raw material composition for nanocapsules Surfactin sodium was added and dissolved in glycerin according to the following formulation, and an oil mixture having the following composition was added little by little while stirring. Further, water and 1,3-butanediol were slowly added while stirring, and finally the oil mixture 60%, glycerin 23%, 1,3-butanediol 13%, and water 3%. A raw material composition for nanocapsules of surfactin sodium 1% was obtained.
(オイル混合物の組成)
以下の脂溶性物質をそれぞれ0.5%重量混合し、最後に残分としてスクワランを添加して100%重量とした。
アスコルビン酸イソパルミチン酸、アスコルビン酸−2−リン酸−6−パルミテート、アスコルビン酸−2−リン酸−6−イソパルミテート、アスコルビン酸−6−パルミテート、アスコルビン酸−2、6−ジパルミテート、アスコルビン酸−6−ステアレート、レチノール、レチノイン酸、レチノールパルミテート、レチノイン酸パルミテート、レチノイン酸イソパルミテート、レチノイン酸ステアレート、レチノールステアレート、アスタキサンチン、ルテイン、リコピン、βカロチン、αカロチン、αトコフェロール、βトコフェロール、γトコフェロール、ジメチルグリシンγトコフェロール、ジメチルグリシンαトコフェロール、ユビキノン、コエンザイムA、トコトリエノール、ミネラル油、流動パラフィン、スクワレン、パルミチン酸イソプロピル、ミリスチン酸イソプロピル、ミリスチン酸イソオクチル、ミリスチン酸イソトリデシル、ミリスチン酸オクタデシル、ミリスチン酸オクチルドデシル、米胚芽油、ミネラル油、流動パラフィン、イソステアリルコレステリルエステル、2−エチルヘキサン酸トリグリセリド、2−エチルヘキサン酸セチル、ヒマワリ油、オリーブ油、ホホバ油、ツバキ油、グレープシード油、アボガド油、マカダミアナッツ油、アーモンド油、米胚芽油、丁字油、オレンジ油、トウヒ油、オクタメチルトリシロキサン、デカメチルテトラシロキサン、メチルポリシロキサン、オクタメチルシクロテトラシロキサン、ピクノジャノール、コエンザイムA、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、メチルシクロポリシロキサン、メチルポリシクロシロキサン、メチルフェニルポリシロキサン(Composition of oil mixture)
Each of the following fat-soluble substances was mixed by 0.5% by weight, and finally squalane was added as a residue to make 100% by weight.
Ascorbic acid isopalmitic acid, ascorbic acid-2-phosphate-6-palmitate, ascorbic acid-2-phosphate-6-isopalmitate, ascorbic acid-6-palmitate, ascorbic acid-2, 6-dipalmitate, ascorbic acid-6 Stearate, retinol, retinoic acid, retinol palmitate, retinoic acid palmitate, retinoic acid isopalmitate, retinoic acid stearate, retinol stearate, astaxanthin, lutein, lycopene, β-carotene, α-carotene, α-tocopherol, β-tocopherol, γ-tocopherol , Dimethylglycine gamma tocopherol, dimethylglycine alpha tocopherol, ubiquinone, coenzyme A, tocotrienol, mineral oil, liquid paraffin, squalene, palmitic Isopropyl acid, isopropyl myristate, isooctyl myristate, isotridecyl myristate, octadecyl myristate, octyldodecyl myristate, rice germ oil, mineral oil, liquid paraffin, isostearyl cholesteryl ester, 2-ethylhexanoic acid triglyceride, 2-ethylhexane Cetyl acid, sunflower oil, olive oil, jojoba oil, camellia oil, grape seed oil, avocado oil, macadamia nut oil, almond oil, rice germ oil, clove oil, orange oil, spruce oil, octamethyltrisiloxane, decamethyltetrasiloxane , Methylpolysiloxane, octamethylcyclotetrasiloxane, picnojanol, coenzyme A, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, methyl Ropolysiloxane, methylpolycyclosiloxane, methylphenylpolysiloxane
実施例4:水分散ナノカプセル
下記の処方Aでグリセリンにサーファクチンナトリウムを溶解し、撹拌しながら脂溶性物質を少量ずつ添加し、ゲルを調製した。
処方Aのゲルを80℃に加温し、80℃に加温して溶解した処方B液を加え、ホモミキサーで5000rpm、5分間撹拌して均一にした。さらに撹拌しながら処方Cのアルギニン水溶液を加え、パドル撹拌しながら冷却し、40℃以下で撹拌を止め、放置した。ナノカプセルの平均粒子経を測定したところ300nmであった。Example 4: Water-dispersed nanocapsules Surfactin sodium was dissolved in glycerin according to the following formulation A, and a fat-soluble substance was added little by little while stirring to prepare a gel.
The gel of the formulation A was heated to 80 ° C., the formulation B solution dissolved by heating to 80 ° C. was added, and the mixture was homogenized with a homomixer at 5000 rpm for 5 minutes. Further, the arginine aqueous solution of Formulation C was added with stirring, the mixture was cooled with paddle stirring, the stirring was stopped at 40 ° C. or lower, and the mixture was allowed to stand. It was 300 nm when the average particle diameter of the nanocapsule was measured.
処方A
脂溶性混合物16%、グリセリン4%、サーファクチンナトリウム0.2%
脂溶性混合物を以下の処方で混合した。
アスコルビン酸イソパルミチン酸、アスコルビン酸−2−リン酸−6−パルミテート、アスコルビン酸−2−リン酸−6−イソパルミテート、アスコルビン酸−6−パルミテート、アスコルビン酸−2、6−ジパルミテート、アスコルビン酸−6−ステアレート、レチノール、レチノイン酸、レチノールパルミテート、レチノイン酸パルミテート、レチノイン酸イソパルミテート、レチノイン酸ステアレート、レチノールステアレート、アスタキサンチン、ルテイン、リコピン、βカロチン、αカロチン、αトコフェロール、βトコフェロール、γトコフェロール、ジメチルグリシンγトコフェロール、ジメチルグリシンαトコフェロール、ユビキノン、コエンザイムA、トコトリエノールの各1%を混合し残分としてスクワランを加えて100%とした。Formula A
16% fat-soluble mixture, 4% glycerin, 0.2% surfactin sodium
The fat-soluble mixture was mixed according to the following formulation.
Ascorbic acid isopalmitic acid, ascorbic acid-2-phosphate-6-palmitate, ascorbic acid-2-phosphate-6-isopalmitate, ascorbic acid-6-palmitate, ascorbic acid-2, 6-dipalmitate, ascorbic acid-6 Stearate, retinol, retinoic acid, retinol palmitate, retinoic acid palmitate, retinoic acid isopalmitate, retinoic acid stearate, retinol stearate, astaxanthin, lutein, lycopene, β-carotene, α-carotene, α-tocopherol, β-tocopherol, γ-tocopherol , Dimethylglycine γ-tocopherol, dimethylglycine α-tocopherol, ubiquinone, coenzyme A, tocotrienol 1% each, and squalene added as a residue. And the.
処方B
赤色3号0.001%、ベヘニルアルコール2%、及びステアリン酸0.5%Formula B
Red No. 3 0.001%, behenyl alcohol 2%, and stearic acid 0.5%
処方C
L−アルギニン0.1%
水 残部Formula C
L-Arginine 0.1%
Water balance
実施例5:水分散ナノカプセル
下記の処方Aでグリセリンにサーファクチンナトリウムを溶解し、撹拌しながら以下の脂溶性物質を少量ずつ添加し、ゲルを調製した。Example 5: Water-dispersed nanocapsules Surfactin sodium was dissolved in glycerin according to the following formulation A, and the following fat-soluble substances were added little by little while stirring to prepare a gel.
処方A
以下の脂溶性混合物16%、グリセリン4%、サーファクチンナトリウム0.2%。脂溶性混合物の組成は以下の通りである。
アスコルビン酸イソパルミチン酸、アスコルビン酸−2−リン酸−6−パルミテート、アスコルビン酸−2−リン酸−6−イソパルミテート、アスコルビン酸−6−パルミテート、アスコルビン酸−2、6−ジパルミテート、アスコルビン酸−6−ステアレート、レチノール、レチノイン酸、レチノールパルミテート、レチノイン酸パルミテート、レチノイン酸イソパルミテート、レチノイン酸ステアレート、レチノールステアレート、アスタキサンチン、ルテイン、リコピン、βカロチン、αカロチン、αトコフェロール、βトコフェロール、γトコフェロール、ジメチルグリシンγトコフェロール、ジメチルグリシンαトコフェロール、ユビキノン、コエンザイムA、トコトリエノールの各1%を混合し残分としてスクワランを加えて100%とした。Formula A
The following fat-soluble mixture 16%, glycerin 4%, surfactin sodium 0.2%. The composition of the fat-soluble mixture is as follows.
Ascorbic acid isopalmitic acid, ascorbic acid-2-phosphate-6-palmitate, ascorbic acid-2-phosphate-6-isopalmitate, ascorbic acid-6-palmitate, ascorbic acid-2, 6-dipalmitate, ascorbic acid-6 Stearate, retinol, retinoic acid, retinol palmitate, retinoic acid palmitate, retinoic acid isopalmitate, retinoic acid stearate, retinol stearate, astaxanthin, lutein, lycopene, beta carotene, alpha carotene, alpha tocopherol, beta tocopherol, gamma tocopherol , Dimethylglycine γ-tocopherol, dimethylglycine α-tocopherol, ubiquinone, coenzyme A, tocotrienol 1% each, and squalene added as a residue. And the.
処方B
ベヘニルアルコール2%、及びステアリン酸0.5%Formula B
2% behenyl alcohol and 0.5% stearic acid
水 残部Water balance
処方Aのゲルを80℃に加温し、80℃に加温して溶解した処方B液を加え、ホモミキサーで5000rpm、5分間撹拌して均一にした。さらに撹拌しながら処方Cのアルギニン水溶液を加え、パドル撹拌しながら冷却し、40℃以下で撹拌を止め、放置して本発明のナノカプセルを作成した。ナノカプセルの平均粒子経を測定したところ350nmであった。 The gel of formulation A was heated to 80 ° C., and the formulation B solution dissolved by heating to 80 ° C. was added, and the mixture was homogenized by stirring at 5000 rpm for 5 minutes with a homomixer. Further, the arginine aqueous solution of Formulation C was added while stirring, and the mixture was cooled while stirring with a paddle. It was 350 nm when the average particle diameter of the nanocapsule was measured.
このナノカプセルを色素沈着治療用及びシワとり用の医薬品、医薬品原料、化粧品、化粧品原料、食品、食品添加物、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、機能性食品、老化防止剤として美白、色素沈着の改善、ニキビの治療、シワの改善、肌荒れの改善、油肌の改善、乾燥肌の改善、毛穴の縮小、瘢痕の治療、赤ら顔の治療、抜け毛の治療、育毛促進、やけどの治療、皮膚の殺菌、皮膚の殺ダニ、皮膚のキメの改善に悩むプラセボを含む男女100人に一日2回(一回につき5CC)を患部に使用させて60日間外用塗布させたところ使用開始時に比較し60日後明らかに病変が改善した。尚イオン導入器、振動導入器、電磁波導入器、温熱導入器、電解導入器については市販のものを使用した。 This nanocapsule for pigmentation treatment and wrinkle removal medicine, pharmaceutical raw material, cosmetic, cosmetic raw material, food, food additive, external preparation, iontophoretic composition, vibration introducing composition, electromagnetic wave introducing composition, Composition for introducing heat, composition for electrolytic introduction, functional food, whitening as anti-aging agent, improvement of pigmentation, treatment of acne, improvement of wrinkles, improvement of rough skin, improvement of oily skin, improvement of dry skin, pores Twice a day for 100 men and women, including placebo suffering from shrinkage, scar treatment, red face treatment, hair loss treatment, hair growth promotion, burn treatment, skin sterilization, skin mite killing, skin texture improvement ( When 5 CC) was applied to the affected area and applied externally for 60 days, the lesion was clearly improved after 60 days compared to the beginning of use. In addition, about the ion introducing device, the vibration introducing device, the electromagnetic wave introducing device, the heat introducing device, and the electrolytic introducing device, commercially available products were used.
またこのカプセルを飼料、飼料添加物、酸化防止剤、抗酸化剤の酸化防止成分として0.5%濃度で添加したところそれぞれの商品の寿命が二倍に延長することができ優れた抗酸化効果を発揮できることを確認した。 Moreover, when this capsule is added at 0.5% concentration as an antioxidant component of feed, feed additives, antioxidants, and antioxidants, the lifespan of each product can be doubled and excellent antioxidant effect It was confirmed that can be demonstrated.
実施例6:水分散製ナノカプセル
下記の処方Aでグリセリンにサーファクチンナトリウムを溶解し、撹拌しながら以下の脂溶性物質を少量ずつ添加し、本発明請求項1のナノカプセル製造用原料を調製した。Example 6 Nanocapsules Made of Water Dispersion In the following formulation A, surfactin sodium is dissolved in glycerin, and the following fat-soluble substances are added little by little while stirring to prepare the raw material for producing nanocapsules according to claim 1 of the present invention. did.
処方A
以下の脂溶性混合物16%、グリセリン4%、サーファクチンナトリウム0.2%脂溶性混合物の組成は以下の通りである。
アスコルビン酸イソパルミチン酸、アスコルビン酸−2−リン酸−6−パルミテート、アスコルビン酸−2−リン酸−6−イソパルミテート、アスコルビン酸−6−パルミテート、アスコルビン酸−2、6−ジパルミテート、アスコルビン酸−6−ステアレート、レチノール、レチノイン酸、レチノールパルミテート、レチノイン酸パルミテート、レチノイン酸イソパルミテート、レチノイン酸ステアレート、レチノールステアレート、アスタキサンチン、ルテイン、リコピン、βカロチン、αカロチン、αトコフェロール、βトコフェロール、γトコフェロール、ジメチルグリシンγトコフェロール、ジメチルグリシンαトコフェロール、ユビキノン、コエンザイムA、トコトリエノールの各1%を混合し残分としてスクワランを加えて100%とした。Formula A
The composition of the following fat-soluble mixture 16%, glycerin 4%, surfactin sodium 0.2% fat-soluble mixture is as follows.
Ascorbic acid isopalmitic acid, ascorbic acid-2-phosphate-6-palmitate, ascorbic acid-2-phosphate-6-isopalmitate, ascorbic acid-6-palmitate, ascorbic acid-2, 6-dipalmitate, ascorbic acid-6 Stearate, retinol, retinoic acid, retinol palmitate, retinoic acid palmitate, retinoic acid isopalmitate, retinoic acid stearate, retinol stearate, astaxanthin, lutein, lycopene, β-carotene, α-carotene, α-tocopherol, β-tocopherol, γ-tocopherol , Dimethylglycine γ-tocopherol, dimethylglycine α-tocopherol, ubiquinone, coenzyme A, tocotrienol 1% each, and squalene added as a residue. And the.
処方B
ベヘニルアルコール2%、及びステアリン酸0.5%Formula B
2% behenyl alcohol and 0.5% stearic acid
水 残部Water balance
処方Aのナノカプセル製造用原料を80℃に加温し、80℃に加温して溶解した処方B液を加え、ホモミキサーで5000rpm、5分間撹拌して均一にした。さらにこのABの混合物と水(残部)を、それぞれスタティックミキサー、ジェットディスパゲーター、ミクロポーラスフィルター、マイクロフルイダイザー及びManton−Gaulinホモジェナイザーノズルで剪断混合して均一に分散させ室温まで自然冷却した。
それぞれの剪断変形方法で分散したナノカプセルの平均粒子経を測定したところスタティックミキサー234nm、ジェットディスパゲーター217nm、ミクロポーラスフィルター210nm、マイクロフルイダイザー94nm及びManton−Gaulinホモジェナイザーノズル153nmであった。The raw material for producing nanocapsules of formulation A was heated to 80 ° C., and the formulation B solution dissolved by heating to 80 ° C. was added, and the mixture was homogenized by stirring at 5000 rpm for 5 minutes. Further, the AB mixture and water (remainder) were sheared and mixed uniformly with a static mixer, a jet dispersator, a microporous filter, a microfluidizer and a Manton-Gaulin homogenizer nozzle, and naturally cooled to room temperature.
When the average particle size of the nanocapsules dispersed by the respective shear deformation methods was measured, they were static mixer 234 nm, jet dispersator 217 nm, microporous filter 210 nm, microfluidizer 94 nm, and Manton-Gaulin homogenizer nozzle 153 nm.
実施例7:
乳液下記の処方Aでグリセリンにサーファクチンナトリウムを溶解し、撹拌しながらスクアランを少量ずつ添加し、ゲルを調製した。処方Aのゲルを70℃に加温し、70℃に加温して溶解した処方B液を加え、ホモミキサーで5000rpm、5分間撹拌して均一にした。さらに撹拌しながら水を処方Cの量加え、パドル撹拌しながら冷却し、40℃以下で撹拌を止め、放置した。Example 7:
Emulsion Surfactin sodium was dissolved in glycerin with the following formulation A, and squalane was added little by little with stirring to prepare a gel. The gel of formulation A was heated to 70 ° C., the formulation B solution dissolved by heating to 70 ° C. was added, and the mixture was homogenized by stirring at 5000 rpm for 5 minutes with a homomixer. Further, water was added in an amount of Formulation C with stirring, and the mixture was cooled with paddle stirring.
処方A
スクアラン16%グリセリン4%サーファクチンナトリウム1%Formula A
Squalane 16% Glycerin 4% Surfactin sodium 1%
処方B
ステアリン酸0.5%ベヘニルアルコール2%防腐剤 適量Formula B
Stearic acid 0.5% behenyl alcohol 2% Preservative
処方C
アルギニン0.1%
水 残部Formula C
Arginine 0.1%
Water balance
実施例8:水分散ナノカプセル
下記の処方Aでグリセリンにサーファクチンナトリウムを溶解し、撹拌しながら以下の脂溶性物質を少量ずつ添加し、ゲルを調製した。Example 8: Water-dispersed nanocapsules Surfactin sodium was dissolved in glycerin according to the following formulation A, and the following fat-soluble substances were added little by little while stirring to prepare a gel.
処方A
以下の脂溶性混合物16%、グリセリン4%、サーファクチンナトリウム0.2%。脂溶性混合物の組成は以下の通りである。
赤色3号10%、αトコフェロールの各1%を混合し残分としてパルミチン酸を加えて100%とした。Formula A
The following fat-soluble mixture 16%, glycerin 4%, surfactin sodium 0.2%. The composition of the fat-soluble mixture is as follows.
10% of Red No. 3 and 1% of α-tocopherol were mixed, and palmitic acid was added as a residue to make 100%.
処方B
ベヘニルアルコール2%、及びステアリン酸0.5%Formula B
2% behenyl alcohol and 0.5% stearic acid
水 残部Water balance
処方Aのゲルを80℃に加温し、80℃に加温して溶解した処方B液を加え、ホモミキサーで5000rpm、5分間撹拌して均一にした。さらに撹拌しながら処方Cのアルギニン水溶液を加え、パドル撹拌しながら冷却し、40℃以下で撹拌を止め、放置して本発明のナノカプセルを作成した。ナノカプセルの平均粒子経を測定したところ345nmであった。 The gel of formulation A was heated to 80 ° C., and the formulation B solution dissolved by heating to 80 ° C. was added, and the mixture was homogenized by stirring at 5000 rpm for 5 minutes with a homomixer. Further, the arginine aqueous solution of Formulation C was added while stirring, and the mixture was cooled while stirring with a paddle. It was 345 nm when the average particle diameter of the nanocapsule was measured.
このナノカプセルを着色材料として医薬品、医薬品原料、化粧品、化粧品原料、食品、食品添加物、外用剤、イオン導入用組成物、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、機能性食品、老化防止剤、飼料、飼料添加物、酸化防止剤、抗酸化剤、塗料、トナー、インキジェット用インキ,インクジェットプリント基板用インキ、写真フィルム用感光粒子の色素として0.5%濃度で添加したところそれぞれの商品の色素が退色するまでの寿命が3倍に延長できることができ、且つ色素粒子が細かいために解像度の優れ、安定性の高いナノサイズの色素粒子となり得ることを確認した。 Using these nanocapsules as coloring materials, pharmaceuticals, pharmaceutical raw materials, cosmetics, cosmetic raw materials, foods, food additives, external preparations, ion introduction compositions, vibration introduction compositions, electromagnetic wave introduction compositions, heat introduction compositions, Composition for electrolytic introduction, functional food, anti-aging agent, feed, feed additive, antioxidant, antioxidant, paint, toner, ink for ink jet, ink for inkjet printed circuit board, dye for photosensitive particle for photographic film When added at a concentration of 0.5%, the life until the dye of each product fades can be extended by a factor of three, and the dye particles are fine, so the resolution is excellent and the nano-sized dye particles have high stability. Confirmed that could be.
実施例9:水分散ナノカプセル
下記の処方Aでグリセリンにサーファクチンナトリウムを溶解し、撹拌しながら以下の脂溶性物質を少量ずつ添加し、ゲルを調製した。Example 9: Water-dispersed nanocapsules Surfactin sodium was dissolved in glycerin according to the following formulation A, and the following fat-soluble substances were added little by little while stirring to prepare a gel.
処方A
以下の脂溶性混合物16%、グリセリン4%、サーファクチンナトリウム0.2%。脂溶性混合物の組成は以下の通りである。
平均粒子経100nmの磁性鉄粉5%、αトコフェロールの各1%を混合し残分としてパルミチン酸を加えて100%として混合し良く練り均一な磁性鉄粉分散脂溶性混合物とした。Formula A
The following fat-soluble mixture 16%, glycerin 4%, surfactin sodium 0.2%. The composition of the fat-soluble mixture is as follows.
5% magnetic iron powder having an average particle diameter of 100 nm and 1% each of α-tocopherol were mixed, and palmitic acid was added as a residue and mixed to 100%, and kneaded well to obtain a uniform magnetic iron powder-dispersed fat-soluble mixture.
処方B
ベヘニルアルコール2%、及びステアリン酸0.5%Formula B
2% behenyl alcohol and 0.5% stearic acid
水 残部Water balance
処方Aのゲルを80℃に加温し、80℃に加温して溶解した処方B液を加え、ホモミキサーで5000rpm、5分間撹拌して均一にした。さらに撹拌しながら処方Cのアルギニン水溶液を加え、パドル撹拌しながら冷却し、40℃以下で撹拌を止め、放置して本発明のナノカプセルを作成した。ナノカプセルの平均粒子経を測定したところ345nmであった。 The gel of formulation A was heated to 80 ° C., and the formulation B solution dissolved by heating to 80 ° C. was added, and the mixture was homogenized by stirring at 5000 rpm for 5 minutes with a homomixer. Further, the arginine aqueous solution of Formulation C was added while stirring, and the mixture was cooled while stirring with a paddle. It was 345 nm when the average particle diameter of the nanocapsule was measured.
このナノカプセルを磁性材料として医薬品、化粧品、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、塗料、トナー、インキジエット用インキ,磁性記憶材料用の磁性粒子として5%濃度で通常のバインダーに添加したところ粒子が細かく、粉体の二次凝集が起こりにくいために記憶密度が3倍に向上し、安定性の高く、記憶密度が高い記憶媒体を作成できることを確認した。 This nanocapsule is used as a magnetic material for pharmaceuticals, cosmetics, vibration-introducing compositions, electromagnetic wave-introducing compositions, heat-introducing compositions, electrolytic-introducing compositions, paints, toners, ink-jet inks, and magnetic memory materials. When added to a normal binder at a concentration of 5% as particles, the particles are fine and the secondary agglomeration of the powder is unlikely to occur, so the storage density is improved 3 times, creating a storage medium with high stability and high storage density I confirmed that I can do it.
実施例10:水分散ナノカプセル
下記の処方Aでグリセリンにサーファクチンナトリウムを溶解し、撹拌しながら以下の脂溶性物質を少量ずつ添加し、ゲルを調製した。Example 10: Water-dispersed nanocapsules Surfactin sodium was dissolved in glycerin according to the following formulation A, and the following fat-soluble substances were added little by little while stirring to prepare a gel.
処方A
以下の脂溶性混合物16%、グリセリン4%、サーファクチンナトリウム0.2%。脂溶性混合物の組成は以下の通りである。導電性フラーレン(C60及びC70の1:1混合物の1,3ブチレングリコール複合物)5%、αトコフェロールの各1%を混合し残分としてパルミチン酸を加えて100%として混合し良く練り均一な導電性粒子分散脂溶性混合物とした。Formula A
The following fat-soluble mixture 16%, glycerin 4%, surfactin sodium 0.2%. The composition of the fat-soluble mixture is as follows. Conductive fullerene (1,3 butylene glycol complex of 1: 1 mixture of C60 and C70) and 1% each of α-tocopherol are mixed, and palmitic acid is added as the residue to make 100%, and kneaded well and uniform A conductive particle-dispersed fat-soluble mixture was obtained.
処方B
ベヘニルアルコール2%、及びステアリン酸0.5%Formula B
2% behenyl alcohol and 0.5% stearic acid
水 残部Water balance
処方Aのゲルを80℃に加温し、80℃に加温して溶解した処方B液を加え、ホモミキサーで5000rpm、5分間撹拌して均一にした。さらに撹拌しながら処方Cのアルギニン水溶液を加え、パドル撹拌しながら冷却し、40℃以下で撹拌を止め、放置して本発明のナノカプセルを作成した。ナノカプセルの平均粒子経を測定したところ2915nmであった。 The gel of formulation A was heated to 80 ° C., and the formulation B solution dissolved by heating to 80 ° C. was added, and the mixture was homogenized by stirring at 5000 rpm for 5 minutes with a homomixer. Further, the arginine aqueous solution of Formulation C was added while stirring, and the mixture was cooled while stirring with a paddle. It was 2915 nm when the average particle diameter of the nanocapsule was measured.
このナノカプセルを導電性材料として医薬品、化粧品、振動導入用組成物、電磁波導入用組成物、温熱導入用組成物、電解導入用組成物、塗料、トナー、インキジエット用インキ,磁性記憶材料用、ピリンタ基盤用の導電性素材として5%濃度で通常のマトリクスに添加したところ粒子が細かく、粉体の二次凝集が起こりにくいためにより細い配線をプリントできるようになり配線密度が2倍に向上し、断線率の低い、配線密度が高いプリント基盤を作成できることを確認した。 Using this nanocapsule as a conductive material for pharmaceuticals, cosmetics, composition for introducing vibration, composition for introducing electromagnetic waves, composition for introducing heat, composition for introducing electrolysis, paint, toner, ink for ink jet, for magnetic memory material, When added to a normal matrix at a concentration of 5% as a conductive material for a pirinta substrate, fine particles are less likely to cause secondary agglomeration of the powder, so finer wiring can be printed and the wiring density is doubled. It was confirmed that a printed board with a low disconnection rate and a high wiring density could be created.
本発明によれば、水及び/又は液状マトリックスの一種以上の単体又はその複合物と、それに溶解、分散された界面活性剤の一種以上の単体又はその複合物と、脂溶性物質の一種以上の単体又はその複合物から構成される原料でナノカプセルを製造することにより安定性が良好で安全性が高く簡便で安価なナノカプセルを製造でき幅広い用途に使用可能なナノカプセルを供給することができる。According to the present invention, one or more simple substances of water and / or a liquid matrix or a composite thereof, one or more simple substances of a surfactant dissolved or dispersed therein or a composite thereof, and one or more of a fat-soluble substance. By producing nanocapsules from a raw material composed of a single substance or a composite thereof, it is possible to produce nanocapsules with good stability, high safety, simple and inexpensive, and capable of supplying nanocapsules that can be used in a wide range of applications. .
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003292633A JP2005028559A (en) | 2003-07-08 | 2003-07-08 | Nanocapsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003292633A JP2005028559A (en) | 2003-07-08 | 2003-07-08 | Nanocapsule |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005028559A true JP2005028559A (en) | 2005-02-03 |
Family
ID=34213373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003292633A Pending JP2005028559A (en) | 2003-07-08 | 2003-07-08 | Nanocapsule |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2005028559A (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007063203A (en) * | 2005-08-31 | 2007-03-15 | Nof Corp | Diabetes remedy |
JP2007202516A (en) * | 2006-02-03 | 2007-08-16 | Step 21:Kk | Dog food |
WO2007102455A1 (en) * | 2006-03-06 | 2007-09-13 | Nippon Kayaku Kabushiki Kaisha | Ink for inkjet printing, and inkjet printing method using the same |
JP2009514811A (en) * | 2005-10-18 | 2009-04-09 | 株式會社アモーレパシフィック | Cationic polymer nanocapsules containing oil-soluble active ingredients and cosmetic compositions containing the same |
JP2009138164A (en) * | 2007-12-10 | 2009-06-25 | Seiko Epson Corp | Conductor pattern forming ink, conductor pattern and wiring board |
JP2009138165A (en) * | 2007-12-10 | 2009-06-25 | Seiko Epson Corp | Conductor pattern forming ink, conductor pattern and wiring board |
JP2009138163A (en) * | 2007-12-10 | 2009-06-25 | Seiko Epson Corp | Conductor pattern forming ink, conductor pattern and wiring board |
JP2009138162A (en) * | 2007-12-10 | 2009-06-25 | Seiko Epson Corp | Conductor pattern forming ink, conductor pattern and wiring board |
JP2011162757A (en) * | 2010-01-13 | 2011-08-25 | Riso Kagaku Corp | Oily inkjet ink |
WO2013002278A1 (en) | 2011-06-28 | 2013-01-03 | 富士フイルム株式会社 | Astaxanthin-containing composition, method for manufacturing same, and cosmetic |
JP2013011462A (en) * | 2011-06-28 | 2013-01-17 | Hirayama Seisakusho:Kk | Method for predicting life of led |
CN103571728A (en) * | 2013-08-16 | 2014-02-12 | 江南大学 | Use of lipopeptide compounds for improving sweet smell of white spirit and determination method of lipopeptide compounds |
JP2017039667A (en) * | 2015-08-20 | 2017-02-23 | 株式会社コーセー | Composition |
JP2018115303A (en) * | 2017-01-20 | 2018-07-26 | 株式会社 先端医療開発 | Dye composition, food, method for inhibiting fading, and method for producing dye composition |
JP2019513359A (en) * | 2016-03-25 | 2019-05-30 | アディッソ・フランス・エス.エー.エス.Adisseo France S.A.S. | Lipocapsule active ingredient nanocapsule and method for producing and using the same |
KR102022508B1 (en) * | 2019-03-18 | 2019-09-18 | 황수경 | Functional oil composition food and method for producing the same |
CN113229362A (en) * | 2021-05-10 | 2021-08-10 | 东北林业大学 | Preparation method of polyanion anti-shrinkage fruit fresh-keeping coating liquid |
WO2022058318A1 (en) * | 2020-09-16 | 2022-03-24 | Technological University Dublin | A conductive alginate capsule encapsulating a healing agent |
CN114504636A (en) * | 2022-01-27 | 2022-05-17 | 华南理工大学 | A kind of almond oil scald cream and its preparation method and application |
JP2023523126A (en) * | 2020-02-19 | 2023-06-02 | インヴェンティオンビオ スポルカ ズ オルガニショナ オドポウィエジアルノシュア | A self-emulsifying composition intended for administration to the skin comprising a biosurfactant, a co-surfactant and an oil phase |
-
2003
- 2003-07-08 JP JP2003292633A patent/JP2005028559A/en active Pending
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007063203A (en) * | 2005-08-31 | 2007-03-15 | Nof Corp | Diabetes remedy |
JP2009514811A (en) * | 2005-10-18 | 2009-04-09 | 株式會社アモーレパシフィック | Cationic polymer nanocapsules containing oil-soluble active ingredients and cosmetic compositions containing the same |
JP2007202516A (en) * | 2006-02-03 | 2007-08-16 | Step 21:Kk | Dog food |
WO2007102455A1 (en) * | 2006-03-06 | 2007-09-13 | Nippon Kayaku Kabushiki Kaisha | Ink for inkjet printing, and inkjet printing method using the same |
US9040623B2 (en) | 2006-03-06 | 2015-05-26 | Nippon Kayaku Kabushiki Kaisha | Ink for inkjet textile printing and an inkjet textile printing method using the same |
JP2009138164A (en) * | 2007-12-10 | 2009-06-25 | Seiko Epson Corp | Conductor pattern forming ink, conductor pattern and wiring board |
JP2009138165A (en) * | 2007-12-10 | 2009-06-25 | Seiko Epson Corp | Conductor pattern forming ink, conductor pattern and wiring board |
JP2009138163A (en) * | 2007-12-10 | 2009-06-25 | Seiko Epson Corp | Conductor pattern forming ink, conductor pattern and wiring board |
JP2009138162A (en) * | 2007-12-10 | 2009-06-25 | Seiko Epson Corp | Conductor pattern forming ink, conductor pattern and wiring board |
JP2011162757A (en) * | 2010-01-13 | 2011-08-25 | Riso Kagaku Corp | Oily inkjet ink |
JP2013011462A (en) * | 2011-06-28 | 2013-01-17 | Hirayama Seisakusho:Kk | Method for predicting life of led |
WO2013002278A1 (en) | 2011-06-28 | 2013-01-03 | 富士フイルム株式会社 | Astaxanthin-containing composition, method for manufacturing same, and cosmetic |
CN103571728A (en) * | 2013-08-16 | 2014-02-12 | 江南大学 | Use of lipopeptide compounds for improving sweet smell of white spirit and determination method of lipopeptide compounds |
JP2017039667A (en) * | 2015-08-20 | 2017-02-23 | 株式会社コーセー | Composition |
JP2019513359A (en) * | 2016-03-25 | 2019-05-30 | アディッソ・フランス・エス.エー.エス.Adisseo France S.A.S. | Lipocapsule active ingredient nanocapsule and method for producing and using the same |
JP2018115303A (en) * | 2017-01-20 | 2018-07-26 | 株式会社 先端医療開発 | Dye composition, food, method for inhibiting fading, and method for producing dye composition |
JP7042470B2 (en) | 2017-01-20 | 2022-03-28 | 株式会社 SENTAN Pharma | Dye composition, food, fading suppressing method, and manufacturing method of dye composition |
KR102022508B1 (en) * | 2019-03-18 | 2019-09-18 | 황수경 | Functional oil composition food and method for producing the same |
JP2023523126A (en) * | 2020-02-19 | 2023-06-02 | インヴェンティオンビオ スポルカ ズ オルガニショナ オドポウィエジアルノシュア | A self-emulsifying composition intended for administration to the skin comprising a biosurfactant, a co-surfactant and an oil phase |
WO2022058318A1 (en) * | 2020-09-16 | 2022-03-24 | Technological University Dublin | A conductive alginate capsule encapsulating a healing agent |
CN113229362A (en) * | 2021-05-10 | 2021-08-10 | 东北林业大学 | Preparation method of polyanion anti-shrinkage fruit fresh-keeping coating liquid |
CN114504636A (en) * | 2022-01-27 | 2022-05-17 | 华南理工大学 | A kind of almond oil scald cream and its preparation method and application |
CN114504636B (en) * | 2022-01-27 | 2023-09-26 | 华南理工大学 | Almond oil scald ointment and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005028559A (en) | Nanocapsule | |
JP4322124B2 (en) | Method for stabilizing bubbles in foam-containing cosmetics | |
JP2000119155A (en) | Skin lotion | |
JP4866607B2 (en) | Emulsified composition | |
JP2012055888A (en) | Emulsion composition | |
CN108137813B (en) | Cured silicone particles and cosmetic materials incorporating cured silicone particles therein | |
JP2000119156A (en) | Skin lotion | |
JP2002212052A (en) | External preparation | |
TW201210627A (en) | Cosmetic composition for amelioration of skin | |
JP2011256154A (en) | Cosmetic material | |
KR20200138729A (en) | Phosphorylcholine group and silicone group-containing copolymer, powder coated with the copolymer and method for producing the same, and use of the copolymer and the powder as a cosmetic | |
US20080031906A1 (en) | Cosmetic Composition and Method for Producing the Same | |
JPWO2017221940A1 (en) | Cosmetic powder treatment agent, cosmetic powder, and cosmetics containing the same | |
WO2013115099A1 (en) | Makeup cosmetic | |
JP3803260B2 (en) | Skin external preparation for whitening | |
JP4360925B2 (en) | Composition for external use | |
JP2001031580A (en) | Preparation for external use for skin | |
JP2010138074A (en) | Aqueous dispersion and aqueous cosmetic | |
JP2001031558A (en) | Skin lotion | |
JP4494795B2 (en) | A method for stabilizing an emulsion cosmetic composition containing a silicone oil. | |
JP2015124220A (en) | Cosmetic | |
JP2005298370A (en) | Skin preparation for external use for preventing aging of skin | |
JP5112673B2 (en) | Ceramide-containing composition and external preparation for skin containing the same | |
CN107427433B (en) | Tyrosinase activity inhibitor and skin external preparation | |
JP3513871B2 (en) | Skin whitening external preparation |